10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to

Commission File No. 001-40251

NEWBURY STREET ACQUISITION CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	85-3985188
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

121 High Street, Floor 3

Boston, MA, 02110

(Address of Principal Executive Offices, including zip code)

(617) 893-3057

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Common Stock and one-half of one Redeemable Warrant	NBSTU	The Nasdaq Stock Market LLC
Common Stock, par value $0.0001 per share	NBST	The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share	NBSTW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐ Large accelerated filer	☐Accelerated filer
☒ Non-accelerated filer	☒Smaller reporting company
	☒ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒  No ☐

As of August 14, 2023 there were 8,917,715 shares of common stock, $0.0001 par value, issued and outstanding.

GLOSSARY OF TERMS

Unless otherwise stated in this Report (as defined below), or the context otherwise requires, references to:

● “ASC” are to the Accounting Standards Codification;

● “ASU” are to the Accounting Standards Update;

● “board of directors,” “board” or “directors” are to the board of directors of the Company (as defined below);

●“Business Combination” are to a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses;

●“Combination Period” are to the 30-month period from the closing of the Public Offering (as defined below) to September 25, 2023, or such earlier date as determined by the board that the Company has to consummate a Business Combination;

●“Company,” “we” or “us” are to Newbury Street Acquisition Corporation, a Delaware corporation;

●“EBC” are to EarlyBirdCapital, Inc., representative of the underwriters for the Company’s initial public offering;

●“Exchange Act” are to the Securities Exchange Act of 1934, as amended;

●“FASB” are to the Financial Accounting Standards Board;

●“Founder Shares” are to shares of our common stock initially purchased by our sponsor in a private placement prior to our initial public offering;

●“GAAP” are to the accounting principles generally accepted in the United States of America;

●“Infinite Reality” are to Infinite Reality, Inc., a Delaware corporation;

●“Infinite Reality Merger Sub” are to Infinity NBIR Company Merger Sub Inc., a Delaware corporation and a direct wholly-owned subsidiary of Pubco (as defined below) in connection with the Merger Agreement (as defined below);

●“Infinite Reality Merger” are to the merger between the Infinite Reality Merger Sub and Infinite Reality, where Infinite Reality will be the surviving entity under the Merger Agreement (as defined below);

●“Infinite Reality Business Combination” are to the proposed business combination transactions involving the Company and Infinite Reality, including all of the transactions contemplated by the Merger Agreement;

●“Investment Company Act” are to the Investment Company Act of 1940, as amended;

●“Jobs Act” are to the Jumpstart Our Business Startups Act of 2012;

●“management” or “management team” refer to our officers and directors;

●“Merger Agreement” are to the Agreement and Plan of Merger, dated December 12, 2022, by and among the Company, Infinite Reality, Infinite Reality Holdings, Inc., Infinity Purchaser Merger Sub Inc., and Infinity NBIR Company Merger Sub Inc., as amended by the First Amendment to the Agreement and Plan of Merger, dated May 15, 2023, and the Second Amendment to the Agreement and Plan of Merger, dated July 21, 2023;

●“Merger Subs” are to the Purchaser Merger Sub (as defined below) and the Infinite Reality Merger Sub;

●“Mergers” are to the Purchaser Merger (as defined below) and the Infinite Reality Merger;

●“Pubco” are to Infinite Reality Holdings, Inc., a Delaware corporation and a direct wholly-owned subsidiary of the Company;

●“Purchaser Merger” are to the merger between the Purchaser Merger Sub and the Company, where the Company will be the surviving entity under with the Merger Agreement;

●“Purchaser Merger Sub” are to Infinity Purchaser Merger Sub Inc., a Delaware corporation and a direct wholly-owned subsidiary of Pubco;

●“Purchaser Party” are to any of the Company, Pubco, and the Merger Subs;

●“Private Units” are to units sold in a private placement to the Sponsor (as defined below) and EBC, with each private unit consisting of one private share and one-half of one private warrant;

●“Private Warrants” are to redeemable warrants consisted in the Private Units.

●“Public Shares” are to the shares of common stock included in the Units (as defined below) sold as part of the units in our public offering (whether they were purchased in our initial public offering or thereafter in the open market);

●“Public Offering” are to the initial public offering consummated by the Company on March 25, 2021;

●“public stockholders” are to the holders of the outstanding Public Shares;

● “Public Warrants” refer to the redeemable warrants sold as part of the Units in our initial public offering;

● this “Report” are to this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023;

● “Representative Shares” are to the shares of common stock issued to the underwriters and their designees at the closing of our initial public offering.

● “SEC” are to the U.S. Securities and Exchange Commission;

● “Second Amended and Restated Certificate of Incorporation” are to the Second Amended and Restated Certificate of Incorporation, as amended, of the Company;

● “Securities Act” are to the Securities Act of 1933, as amended;

● “SPAC” or “SPACs” are to special purpose acquisition companies;

● “Sponsor” are to Newbury Street Acquisition Sponsor LLC;

● “Trust Account” are to the U.S.-based trust account in which the net proceeds of the sale of the units in the initial public offering and the private placement units was placed following the closing of the initial public offering; and

● “Units” are to the units sold in the Public Offering.

NEWBURY STREET ACQUISITION CORPORATION

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2023

TABLE OF CONTENTS

		Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022		1
Condensed Statements of Operations for the Three and Six Months Ended June 30, 2023 and for the Three and Six Months Ended June 30, 2022 (Unaudited)		2
Condensed Statements of Changes in Stockholders’ (Deficit) Equity for the Three and Six Months Ended June 30, 2023 and for the Three and Six Months Ended June 30, 2022 (Unaudited)		3
Condensed Statements of Cash Flows for the Six Months Ended June 30, 2023 and for the Six Months Ended June 30, 2022 (Unaudited)		4
Notes to Condensed Financial Statements (Unaudited)		5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	32
Item 4.	Control and Procedures	33
Part II – OTHER INFORMATION
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3.	Defaults Upon Senior Securities	35
Item 4.	Mine Safety Disclosures	35
Item 5.	Other Information	35
Item 6.	Exhibits	36
SIGNATURES		37

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NEWBURY STREET ACQUISITION CORPORATION

CONDENSED BALANCE SHEETS

	June 30,		December 31,
	2023		2022
	(Unaudited)
ASSETS
Current Assets
Cash	$	14,472	$	83,643
Prepaid expenses - current		—		47,625
Total Current Assets		14,472		131,268
Cash held in Trust Account		53,327,162		129,951,121
Total Assets	$	53,341,634	$	130,082,389
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accrued expenses	$	2,285,752	$	1,767,679
Excise duty payable		787,706		—
Income tax payable		488,260		413,919
Franchise tax payable		19,949		45,816
Related party payable		480		480
Promissory note - related party		721,327		399,903
Extension loan		700,000		—
Derivative warrant liabilities		38,654		14,241
Total Current Liabilities		5,042,128		2,642,038
Commitments and Contingencies (Note 6)
Common stock subject to possible redemption; 5,099,852 shares as of June 30, 2023, and 12,843,937 shares as of December 31, 2022, at redemption value		52,738,744		129,951,121
STOCKHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—		—
Common stock, $0.0001 par value; 100,000,000 shares authorized; 3,817,863 shares issued and outstanding, excluding 5,099,852 shares as of June 30, 2023, and 12,843,937 shares as of December 31, 2022, subject to possible redemption		382		382
Additional paid-in capital		100,000		—
Accumulated deficit		(4,539,620)		(2,511,152)
Total Stockholders’ Deficit		(4,439,238)		(2,510,770)
Total Liabilities, Common stock subject to possible redemption and Stockholders’ Deficit	$	53,341,634	$	130,082,389

The accompanying notes are an integral part of the unaudited condensed financial statements.

1

NEWBURY STREET ACQUISITION CORPORATION

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months		Three Months		Six Months		Six Months
	Ended		Ended		Ended		Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Formation and operating costs	$	380,474	$	219,959	$	956,135	$	497,615
Franchise tax expense		50,000		50,000		100,000		100,000
Loss from operations		(430,474)		(269,959)		(1,056,135)		(597,615)
Other income:
Change in fair value of derivative warrant liabilities		(29,519)		28,482		(24,413)		95,617
Dividend income		507,720		173,437		1,886,450		186,371
Other income		—		—		—		5,000
Profit (loss) before provision for income taxes		47,727		(68,040)		805,902		(310,627)
Income tax expense		(125,049)		(4,066)		(488,418)		(4,066)
Net (loss) profit	$	(77,322)	$	(72,106)	$	317,484	$	(314,693)
Weighted average shares outstanding, basic and diluted, redeemable common stock		5,099,852		12,843,937		8,541,668		12,843,937
Basic and diluted net (loss) profit per share, redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)
Weighted average shares outstanding, basic and diluted, non-redeemable common stock		3,817,863		3,817,863		3,817,863		3,817,863
Basic and diluted net (loss) profit per share, non-redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)

The accompanying notes are an integral part of the unaudited condensed financial statements.

2

NEWBURY STREET ACQUISITION CORPORATION

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

				Additional				Total
	Common Stock			Paid-in		Accumulated		Stockholders’
	Shares	Amount		Capital		Deficit		Deficit
Balance – January 1, 2023	3,817,863	$	382	$	—	$	(2,511,152)	$	(2,510,770)
Accretion for common stock to redemption amount	—		—		—		(1,105,575)		(1,105,575)
Excise duty in connection with redemption of redeemable shares	—		—		—		(787,706)		(787,706)
Net profit	—		—		—		394,806		394,806
Balance - March 31, 2023	3,817,863		382		—		(4,009,627)		(4,009,245)
Accretion for common stock to redemption amount	—		—		—		(452,671)		(452,671)
Monthly Extension Fee Provided by Infinite Reality	—		—		100,000		—		100,000
Net loss	—		—		—		(77,322)		(77,322)
Balance – June 30, 2023	3,817,863	$	382	$	100,000	$	(4,539,620)	$	(4,439,238)

	Six Months Ended June 30, 2022
								Total
	Common Stock			Additional		Accumulated		Stockholders’
	Shares	Amount		Paid-in Capital		Deficit		Deficit
Balance — January 1, 2022	3,817,863	$	382	$	882,581	$	(594,303)	$	288,660
Net loss	—		—		—		(242,587)		(242,587)
Balance - March 31, 2022	3,817,863		382		882,581		(836,890)		46,073
Accretion for common stock to redemption amount	—		—		(186,329)		—		(186,329)
Net loss	—		—		—		(72,106)		(72,106)
Balance - June 30, 2022	3,817,863	$	382	$	696,252	$	(908,996)	$	(212,362)

The accompanying notes are an integral part of the unaudited condensed financial statements.

3

NEWBURY STREET ACQUISITION CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Six Months Ended		Six Months Ended
	June 30, 2023		June 30, 2022
Cash Flows from Operating Activities:
Net profit (loss)	$	317,484	$	(314,693)
Adjustments to reconcile net profit (loss) to net cash used in operating activities:
Change in fair value of derivative warrant liabilities		24,413		(95,617)
Dividend earned from Trust Account		(1,886,450)		(186,371)
Changes in operating assets and liabilities:
Prepaid expenses - current		47,625		50,691
Prepaid expenses - non-current		—		47,625
Accrued expenses		518,073		(1,367)
Franchise tax payable		(25,867)		(169,421)
Income tax payable		74,341		4,066
Related party payable		—		480
Net cash used in operating activities		(930,381)		(664,607)
Cash Flows from Investing Activities:
Deposit into Trust Account for extension		(800,000)		—
Transfer from Trust Account		539,786		9,500
Cash withdrawn from Trust account in connection with redemption		78,770,623		—
Net cash (used in) provided by investing activities		78,510,409		9,500
Cash Flows from Financing Activities:
Proceeds from promissory note – related party		321,424		230,367
Proceeds from extension loan – related party		700,000		—
Proceeds from Infinite Reality for extension		100,000		—
Payment for Redemption		(78,770,623)		—
Net cash provided by financing activities		(77,649,199)		230,367
Net Change in Cash		(69,171)		(424,740)
Cash - Beginning of period		83,643		435,936
Cash - End of period	$	14,472	$	11,196
Non-cash investing and financing activities:
Accretion for common stock to redemption amount	$	1,558,246	$	186,329
Excise tax payable	$	787,706	$	—

The accompanying notes are an integral part of the unaudited condensed financial statements.

4

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS

Newbury Street Acquisition Corporation (the “Company”) was incorporated in Delaware on November 6, 2020. The Company is a blank check formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

While the Company may pursue a Business Combination target in any business or industry, the Company intends to focus its search on a technology business in the consumer internet or media space, including sports and entertainment verticals. In particular, the Company shall focus on disruptive, high growth companies with a global ambition that take advantage of: (a) the rise of new consumer behaviors driven by the internet or new technologies, or (b) paradigm shifts in media, sports and entertainment that give rise to disruptive new entrants here to stay for the coming decades. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2023, the Company had no operating activity. During the period from January 15, 2021 (commencement of operations) to June 30, 2023, the Company’s activity up to the Public Offering related to the Company’s formation and Public Offering, which is described below, and subsequent to the Public Offering, the search for and consummation of a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income or dividend income derived from the funds deposited in Trust Account. The Company has selected December 31 as its fiscal year end.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account, excluding taxes payable on the income earned on the Trust Account at the time of the Company’s signing a definitive agreement in connection with its initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target business or assets sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide the public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata income earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption are recorded at redemption value and are classified as temporary equity upon the completion of the Public Offering in accordance with the ASC Topic 480 “Distinguishing Liabilities from Equity.”

5

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Second Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares and any Public Shares purchased during or after the Public Offering (a) in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Second Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.

The Company initially had up to 24 months from the closing of the Public Offering to March 25, 2023 to complete a Business Combination, which was extended to September 25, 2023 at the special meeting of the Company’s stockholders on March 21, 2023. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including income earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $0.10 million of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.00).

6

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act.

Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Merger Agreement

On December 12, 2022, the Company, entered into the Merger Agreement by and among (i) the Company, (ii) Pubco, (iii) Purchaser Merger Sub, (iv) Company Merger Sub, and (v) Infinite Reality.

Pursuant to the terms of the Merger Agreement, (i) Purchaser Merger Sub will merge with and into the Company, with the Company continuing as the surviving entity, (ii) Company Merger Sub will merge with and into Infinite Reality, with the Infinite Reality continuing as the surviving entity, and (iii) following the Mergers, the Company and Infinite Reality will become direct wholly-owned subsidiaries of Pubco, and Pubco will become a publicly traded company.

On May 15, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and Infinite Reality entered into the first amendment to the Merger Agreement (the “First Merger Amendment”) to provide for (i) a revised definition of "fully diluted shares", (ii) the removal of Section 7.2(b) of the Merger Agreement (Minimum Cash Condition) in its entirety; and (iii) the addition of a new Section 6.23 providing for the payment by the Company of all transaction expenses up to $10 million in connection with the consummation of the Mergers and the other transactions contemplated by the Merger Agreement.

On July 21, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and Infinite Reality entered into a second amendment to the Merger Agreement (the “Second Merger Amendment”) to provide for the addition of a new Section 6.24 pursuant to which Infinite Reality agrees to pay a “Monthly Extension Fee” of $200,000 per month directly into the Trust Account on behalf of the Company, on or before the date when such payment becomes due, until the completion of the Mergers. In addition, if the Merger Agreement is terminated for any reason other than a breach by the Company, Infinite Reality agrees to pay all expenses of the Company incurred after March 31, 2023, provided that in no event shall such payment exceed $3,000,000 (inclusive of all Monthly Extension Fees paid). In the event that the Mergers are consummated, the Company agrees to pay for all transaction expenses up to $10,000,000 in connection with the consummation of the Mergers and the other transactions contemplated by the Merger Agreement.

7

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)

Stockholder Extension Meeting

On March 3, 2023, the Company filed a definitive proxy statement for a special meeting on March 21, 2023 (the “Special Meeting”) to seek approval from its stockholders to amend the Second Amended and Restated Certificate of Incorporation to further extend the date by which the Company is required to complete its initial Business Combination from March 25, 2023 to September 25, 2023 (the “Extension Proposal”) and to approve the adjournment of the Special Meeting to a later date or dates, if necessary or convenient, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Proposal (the “Adjournment Proposal”). The Extension Proposal and Adjournment Proposal were approved on March 21, 2023.

In connection with approval of the Extension Proposal, the holders of 7,744,085 shares of common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.17 per share, for an aggregate redemption amount of approximately $78.8 million.

On March 23, 2023, the Company filed an amendment to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to extend the date by which the Company has to consummate a Business Combination from March 25, 2023 to September 25, 2023.

Additionally, in connection with the approval of the Extension Proposal, the Sponsor or its designees have agreed to contribute to the Company as a note (i) the lesser of (a) an aggregate of $600,000 or (b) $0.04 for each public share on a monthly basis that is not redeemed in connection with the Extension Amendment for the portion of the Extension ending on June 23, 2023 (the “Initial Contribution”); plus, (ii) an aggregate of $200,000 per month (commencing on June 23, 2023 and on the 23rd day of each subsequent month) until the charter extension date (each, an “Extension Period”), or portion thereof, that is needed to complete an initial Business.

Combination (each monthly payment, a “Monthly Extension Fee” and, together with the Initial Contribution, the “Contribution”), which amount will be deposited into the Trust Account. Accordingly, the amount deposited per share depends on the number of public shares that remain outstanding after the redemption and the length of the extension period that will be needed to complete an initial Business Combination.

On March 24, 2023, the Sponsor made the Initial Contribution of $600,000, which was deposited into the Trust Account.

On June 26, 2023, a Monthly Extension Fee of $200,000 was deposited into the Trust Account, which was comprised of a $100,000 payment from the Sponsor and a $100,000 payment from Infinite Reality (Refer to Note 6).

On July 21, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and the Infinite Reality entered into the Second Merger Amendment pursuant to which Infinite Reality agreed to pay the Monthly Extension Fee of $200,000 per month directly into the Trust Account on behalf of the Company, on or before the date when such payment becomes due, until the completion of the Mergers.

On July 21, 2023, Infinite Reality deposited a Monthly Extension Fee of $200,000 directly into the Trust Account on behalf of the Company, bringing the balance of the Contribution outstanding to $1.0 million.

8

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)

Liquidity and Going Concern

As of June 30, 2023, the Company had approximately $0.01 million in its operating bank account, approximately $53.33 million of cash held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and a working capital deficiency of approximately $5.13 million. In connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders, approximately $78.8 million was removed from the Trust Account on April 3, 2023. As of June 30, 2023, the Company had approximately $53.33 million in its Trust Account.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account performing due diligence on prospective target businesses, including for the Infinite Reality Business Combination, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through September 25, 2023, the date that the Company will be required to cease all operations, except for the purpose of winding up, if a Business Combination is not consummated. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

9

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the GAAP for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 31, 2023. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.

10

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2023 and December 31, 2022, the Company did not have any cash equivalents, outside of funds held in the Trust Account.

As of June 30, 2023 and December 31, 2022, the Company had cash of approximately $0.01 million and $0.08 million, respectively, outside of funds held in the Trust Account.

Cash Held in Trust Account

At June 30, 2023 and December 31, 2022, the Company had approximately $53.33 million and $129.95 million, respectively, of assets held in the Trust Account in an interest-bearing demand deposit account and in Treasury Bills. respectively.

On April 3, 2023, approximately $78.8 million was removed from the Trust Account in connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders subsequent to the approval of the Extension Proposal.

On April 11, 2023, the Company liquidated the funds held in the Trust Account and instead holds the funds in the Trust Account in an interest bearing demand deposit account until the earlier of the consummation of our Business Combination or the Company’s liquidation.

On June 26, 2023, a Monthly Extension Fee of $200,000 was deposited into the Trust Account, which was comprised of a $100,000 payment from the Sponsor and a $100,000 payment from Infinite Reality. The monthly extension payment of $100,000 deposited into the Trust Account by Infinite Reality is non-reimbursable by the Company or the Sponsor.

On July 21, 2023, pursuant to the Second Merger Amendment, Infinite Reality deposited a Monthly Extension Fee of $200,000 directly into the Trust Account on behalf of the Company, bringing the balance of the Contribution outstanding to $1.0 million. Any monthly extension payment deposited into the Trust Account by Infinite Reality is non-reimbursable by the Company or the Sponsor.

Common Stock Subject to Possible Redemption

All of the 12,843,937 shares of common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation if there is a stockholder vote or tender offer in connection with the Business Combination. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC Topic 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC Topic 480.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of common stock are affected by charges against additional paid-in capital and accumulated deficit.

11

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Common Stock Subject to Possible Redemption (Continued)

As of June 30, 2023 and December 31, 2022, the shares of common stock subject to possible redemption and included as temporary equity were as follows:

	As of		As of
	June 30, 2023		December 31, 2022
Gross proceeds	$	129,951,121	$	128,439,370
Plus:
Accretion of carrying value to redemption value		1,558,248		1,511,751
Stockholders redemptions		(78,770,623)		—
Contingently redeemable common stock	$	52,738,744	$	129,951,121

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are charged against the carrying value of common stock or stockholders’ deficit based on the relative value of the shares of common stock and the warrants, to the proceeds received from the Units sold upon the completion of the Public Offering. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Public Offering that were directly related to the Public Offering. The Company incurred offering costs amounting to $3.00 million as a result of the Public Offering, consisting of $2.57 million of cash underwriting discount and $0.43 million of other offering costs. As such, the Company recorded $2.90 million of offering costs as a reduction of temporary equity, $0.10 million of offering costs as a reduction of permanent equity and $454 of offering cost as reduction in the statement of operations.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the federal depository insurance coverage of $0.25 million. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

12

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

● Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

● Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

● Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

As of June 30, 2023 and December 31, 2022, the carrying values of cash, prepaid expenses, accrued expenses, franchise tax payable approximated their fair values due to the short-term nature of the instruments.

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Subtopic 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The 203,440 Private Warrants are recognized as derivative liabilities in accordance with ASC Subtopic 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the Private Warrants was initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Warrants have been estimated using a Monte Carlo simulation model each measurement date.

13

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Net (Loss) Profit Per Share of Common Stock

The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net  (loss) profit per share of common stock is computed by dividing the pro rata net  (loss) profit between the shares of common stock subject to redemption and the shares of common stock not subject to redemption by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted (loss) profit per share of common stock does not consider the effect of the warrants issued in connection with the Public Offering since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 6,625,409 shares of common stock in the aggregate.

	Three Months Ended		Three Months Ended		Six Months Ended		Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Common stock subject to possible redemption
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$	(44,219)	$	(55,584)	$	219,413	$	(242,585)
Denominator:
Weighted average shares outstanding, redeemable common stock		5,099,852		12,843,937		8,541,668		12,843,937
Basic and diluted net (loss) profit per share, redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)
Non-redeemable common stock
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$	(33,103)	$	(16,522)	$	98,071	$	(72,108)
Denominator:
Weighted average shares outstanding, non-redeemable common stock		3,817,863		3,817,863		3,817,863		3,817,863
Basic and diluted net (loss) profit per share, non-redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)

14

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Income Taxes

The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.

The Company recorded income tax expense of $0.49 million based on activities through June 30, 2023, primarily as a result of investment income, partially offset by deductible expenses. The Company's year to date effective tax rate for the second quarter ended June 30, 2023 was 60.61% compared to (1.31%) in the year to date second quarter ended June 30, 2022. The Company's effective rate for the standalone second quarter ended June 30, 2023 was 262% compared to 5.98% in the standalone second quarter ended June 30, 2022. The 2023 year to date effective rate of 60.61% differs from the statutory tax rate of 21% mainly due to permanent nondeductible GAAP expenses, state income taxes and change in the valuation allowance. The standalone second quarter ended June 30, 2023 effective rate of 262% differs from the statutory tax rate of 21% mainly due to permanent non-deductible GAAP expenses, state income taxes and change in the valuation allowance.

The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.

The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying statement of operations. As of June 30, 2023, the Company does not have uncertain tax positions or interest and penalties related to uncertain tax positions.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was enacted into law. Among other changes to the tax code, the act imposes a 1% excise tax on certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022. The stock buyback tax may be applicable to certain SPAC redemptions, including in connection with a SPAC’s business combination. For purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, a number of exceptions to the stock buyback tax are available including exceptions to certain reorganizations; however, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.

15

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Income Taxes (Continued)

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension a vote by stockholders to extend the period of time to complete the Business Combination (the “extension vote”) or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. As of June 30, 2023, $0.79 million was incurred by the Company as excise tax expense in connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders.

The IRS issued Notice 2023-3 (Initial guidance regarding the application of the excise tax on repurchases of corporate stock). The notice defines stock redemptions per Internal Revenue Code (IRC) section 317(b) and also defines transactions considered to be economically similar to a repurchase including certain acquisitive reorganizations, split-offs and certain overlap complete liquidations. Further, the notice defines transaction that are not economically similar transactions including complete liquidations and certain divisive transactions.

Recent Accounting Pronouncements

In August 2020, FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments.

The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2023, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06 on its financial statements.

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

16

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 3 ─ PUBLIC OFFERING

On March 25, 2021, the Company closed on the sale of 12,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of the Company’s common stock, $0.0001 par value and one-half of one redeemable Public Warrant. Each whole Public Warrant offered in the Offering is exercisable to purchase one share of the Company’s common stock at an exercise price of $11.50 per share.

On March 30, 2021, the underwriters exercised the over-allotment option in part and purchased an additional 843,937 Units, generating gross proceeds of $8.44 million.

In connection with the Public Offering, the Company granted the underwriters an option to purchase 1,800,000 shares of the Company’s common stock at the Public Offering price, or $10.00 per share, for 45 days commencing on October 25, 2021 (grant date). Since this option extended beyond the closing of the Public Offering, this option feature represented a call option that was accounted for under ASC 480, Distinguishing Liabilities from Equity. Accordingly, the call option has been separately accounted for at a fair value with the change in fair value between the grant date and March 30, 2021 and expiration amount recorded as other income. The Company used the Black-Scholes valuation model to determine the fair value of the call option at the grant date and again at March 30, 2021 (refer to Note 9 for fair value information).

NOTE 4 ─ PRIVATE UNITS

Concurrently with the closing of the Public Offering, the Sponsor and the underwriters purchased an aggregate of 390,000 Private Units generating gross proceeds of $3.90 million in aggregate in a private placement. Each private unit consists of one share of the Company’s common stock, $0.0001 par value and one-half of one redeemable Private Warrant. Each whole Private Warrant will entitle the holder to purchase one share of common stock at a price of $11.50 per full share, subject to adjustment (see Note 8).

As a result of the underwriters’ election to partially exercise their over-allotment option on March 30, 2021, the Sponsor and the underwriters and its designees purchased an additional 16,879 Private Units, at a purchase price of $10.00 per Private Unit.

If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

NOTE 5 – RELATED PARTY TRANSACTIONS

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Each loan would be evidenced by promissory note.

The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1.50 million of notes may be converted upon completion of a Business Combination into units at a price of $10.00 per unit. Such units would be identical to the Private Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

17

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 5 – RELATED PARTY TRANSACTIONS (Continued)

Related Party Loans (Continued)

On May 3, 2022, the Company issued a promissory note for up to approximately $0.4 million (the “Note”) to the Sponsor, of which $0.4 million was outstanding under the Note as of December 31, 2022. The Note is non-interest bearing and the Company must make drawdown requests in amounts no less than $10,000 unless otherwise agreed upon by the parties. The principal balance of the Note is payable on the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective (such date, the “Maturity Date”). The Company, pursuant to the Note, may at any time prior to payment in full of the principal balance of the Note elect to convert all or any portion of the unpaid principal balance of the Note into units at a conversion price of $10.00 per unit.

However, on March 15, 2023, the Company amended and restated the Note (the “Amended Note”) in its entirety to (1) increase the principal amount thereunder from $0.4 million to $0.9 million and (2) remove the right of the holder of the Amended Note to convert all or any portion of the unpaid principal balance of the note into the Company’s units and related registration rights for such units (including underlying securities). The Amended Note is non-interest bearing and is payable on the Maturity Date.

On March 22, 2023, the Company amended and restated the Note (the “Second Amended Note”) to increase the principal amount of up to $0.9 million to up to $2.1 million to the Sponsor, pursuant to which the Sponsor agreed to loan to the Company up to such amount.

In April 2023, $49,140 was drawn down under the Second Amended Note. In May 2023, an additional aggregate of $221,449 was drawn down under the Second Amended Note. In June 2023, an additional aggregate of $83,500 was drawn down, and an aggregate of $102,665 was refunded, under the Second Amended Note.

At June 30, 2023 and December 31, 2022, approximately $0.72 million and $0.40 million were outstanding under the Second Amended Note, respectively.

Extension Loan

The Sponsor or its designees have agreed to contribute to the Company as a note to fund the Contribution. The Initial Contribution was deposited into the Trust Account on March 24, 2023. Additionally, an aggregate of $200,000 per month of Monthly Extension Fee will be funded throughout the Extension Period, or portion thereof, that is needed to complete an initial Business Combination, which amount will be deposited into the Trust Account.

On June 26, 2023, a Monthly Extension Fee of $200,000 was deposited into the Trust Account, which was comprised of a $100,000 payment from the Sponsor, bringing the balance of the extension loan outstanding to $0.7 million as of June 30, 2023. The other $100,000 payment was from Infinite Reality and this amount is non-reimbursable by the Company or the Sponsor.

Related Party Payable

As of June 30, 2023, an amount of $480 was payable to the Sponsor, in connection with the filing of a tax return.

Administrative Support Agreement

The Company has agreed to pay the Sponsor a total of up to $0.01 million per month from the effective date of the Registration Statement for office space, utilities and secretarial and administrative support. Services will terminate upon the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company. For the six months ended June 30, 2023, the Company has accrued $0.06 million for these services. For the six months ended June 30, 2022, the Company paid $0.04 million and accrued $0.02 million for these services. These amounts are included in the operating costs on the accompanying condensed statements of operations.

18

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 6 – COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on March 22, 2021, the holders of the Founder Shares and Representative Shares, as well as the holders of the Private Units (and underlying securities) and any warrants issued in payment of Working Capital Loans made to Company (and underlying securities) are entitled to registration rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities.

The holders of a majority of the Representative Shares, Private Units and warrants issued in payment of Working Capital Loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. Notwithstanding anything to the contrary, EBC may only make a demand on one occasion and only during the five-year period beginning on the effective date of the registration statement of which this prospectus forms a part. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to consummation of a Business Combination; provided, however, that EBC may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the registration statement of which this prospectus forms a part.

The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of Public Offering to purchase up to 1,800,000 additional Units to cover over-allotments, if any, at the Public Offering price less the underwriting discounts and commissions.

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $2.40 million in the aggregate, paid at the closing of the Public Offering.

On March 30, 2021, the underwriters partially exercised their over-allotment option to purchase an additional 843,937 Units at $10.00 per Unit.

In connection with the underwriters’ partial exercise of the over-allotment option on March 30, 2021, the underwriters were paid an additional cash underwriting fee of approximately $0.17 million.

19

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 6 – COMMITMENTS AND CONTINGENCIES (Continued)

Business Combination Marketing Agreement

The Company has engaged EBC as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination.

The Company will pay EBC a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of Public Offering (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at the Company’s sole discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.

Additionally, the Company will pay EBC a cash fee equal to 1.0% of the total consideration payable in a Business Combination if EBC introduces the Company to the target business with which the Company completes a Business Combination; provided that the foregoing fee will not be paid prior to the date that is 90 days from the effective date of the Public Offering, unless FINRA determines that such payment would not be deemed underwriters’ compensation in connection with the Public Offering pursuant to FINRA Rule 5110(c)(3)(B)(ii).

NOTE 7 ─ STOCKHOLDERS’ DEFICIT

Preferred Stock

The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

Common Stock

The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. On January 15, 2021, the Company issued 4,562,500 shares of common stock to the Sponsor and the underwriters and its designees. On March 22, 2021, the Sponsor and the underwriters effected a surrender of 862,500 and 50,000 shares of common stock to the Company, for no consideration. This resulted in a decrease in the total number of shares of common stock outstanding from 4,562,500 to 3,650,000. All shares and associated amounts have been retroactively restated to reflect the share surrender.

On March 30, 2021, as a result of the underwriters’ election to partially exercise the over-allotment option, an aggregate of 239,016 Founder Shares has been forfeited. As of June 30, 2023 and December 31, 2022, there were 3,817,863 shares of common stock issued and outstanding, excluding 5,099,852 shares of common stock as of June 30, 2023, and 12,843,937 shares of common stock as of December 31, 2022, respectively, that are subject to possible redemption at the option of the holders which accordingly are classified as temporary equity in the accompanying balance sheets.

20

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 7 ─ STOCKHOLDERS’ DEFICIT (Continued)

Public Warrants

The Public Warrants will become exercisable at any time commencing 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available.

If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company may redeem the Public Warrants (excluding the Private Warrants and any warrants underlying units issued upon conversion of the Working Capital Loans):

● in whole and not in part;

● at a price of $0.01 per warrant;

● at any time after the warrants become exercisable;

● upon not less than 30 days’ prior written notice of redemption to each warrant holder;

● if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and

● if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

21

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 7 ─ STOCKHOLDERS’ DEFICIT (Continued)

Public Warrants (Continued)

In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) Market Value or (ii) the price at which the Company issue the additional shares of common stock or equity-linked securities.

Representative Shares

If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

In January 2021, the Company issued to EBC and its designees, 250,000 Representative Shares.

On March 22, 2021, 50,000 Representative Shares were returned by EBC and its designees to the Company, for no consideration. This resulted in a decrease in the total number of Representative Shares outstanding from 250,000 to 200,000.

The Company accounted for the Representative Shares as an offering cost of the Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of Representative Shares to be $1,449 based upon the price of the Founder Shares issued to the Sponsor.

The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their redemption rights with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period.

The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Public Offering pursuant to Rule 5110(g)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities were not sold during the Public Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the Public Offering, except to any underwriter and selected dealer participating in the Public Offering and their bona fide officers or partners, provided that all securities so transferred remain subject to the lockup restriction above for the remainder of the time period.

22

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 8 – DERIVATIVE WARRANTS LIABILITIES

The Private Warrants are identical to the Public Warrants underlying the Units being sold in the Public Offering, except that the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable or saleable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

NOTE 9 – FAIR VALUE MEASUREMENTS

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

● Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

● Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

● Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.

The fair value of the Private Warrants was initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Warrants have been estimated using a Monte Carlo simulation model each measurement date.

For the six months ended June 30, 2023, the Company recognized a loss to the statements of operations resulting from an increase in the fair value of liabilities of $24,413, and for the six months ended June 30, 2022, the Company recognized a gain to the statements of operations resulting from a decrease in the fair value of liabilities of $95,617, respectively, presented as change in fair value of derivative warrant liabilities in the accompanying statements of operations.

23

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 9 – FAIR VALUE MEASUREMENTS (Continued)

The following table presents information about the Company’s financial assets and liablities that were measured at fair value on a recurring basis at June 30, 2023, by level within the fair value hierarchy:

	Quoted Prices in		Significant Other		Significant Other
	Active Markets		Observable Inputs		Unobservable Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Derivative warrant liabilities - Private	$	—	$	—	$	38,654
	$	—	$	—	$	38,654

At June 30, 2023, assets held in the Trust Account comprised of $53.3 million in an interest-bearing Demand Deposit Account.

The following table presents information about the Company’s financial assets and liablities that were measured at fair value on a recurring basis as of December 31, 2022, by level within the fair value hierarchy:

			Significant		Significant
	Quoted Prices		Other		Other
	in Active		Observable		Unobservable
	Markets		Inputs		Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Assets:
Treasury Bills	$	129,951,121	$	—	$	—
	$	129,951,121	$	—	$	—
Liabilities:
Derivative warrant liabilities - Private	$	—	$	—	$	14,241
	$	—	$	—	$	14,241

Transfers to/from Levels 1, 2 and 3 were recognized at the end of the reporting period.

The estimated fair value of the Private Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

24

NEWBURY STREET ACQUISITION CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 9 – FAIR VALUE MEASUREMENTS (Continued)

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:

	June 30, 2023			December 31, 2022
Exercise price	$	11.50		$	11.50
Stock price		10.38			9.71
Volatility		5.3	%		10.4	%
Probability of completing a Business Combination		90.1	%		90.0	%
Term (in years)		5.26			5.74
Risk-free rate		4.03	%		1.32	%

The change in the fair value of the derivative warrant liabilities for the three and six months ended June 30, 2023, is summarized as follows:

Derivative warrant liabilities at December 31, 2022	$	14,241
Change in fair value of derivative warrant liabilities		(5,106)
Derivative warrant liabilities at March 31, 2023		9,135
Change in fair value of derivative warrant liabilities		29,519
Derivative warrant liabilities at June 30, 2023	$	38,654

NOTE 10 – SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Other than as described herein, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

On July 21, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and Infinite Reality entered into the Second Merger Amendment to provide for the addition of a new Section 6.24 pursuant to which Infinite Reality agrees to pay a “Monthly Extension Fee” of $0.2 million per month directly into the Trust Account on behalf of the Company, on or before the date when such payment becomes due, until the completion of the Mergers. In addition, if the Merger Agreement is terminated for any reason other than a breach by the Company, Infinite Reality agrees to pay all expenses of the Company incurred after March 31, 2023, provided that in no event shall such payment exceed $3 million (inclusive of all Monthly Extension Fees paid). In the event that the Mergers are consummated, the Company agrees to pay for all transaction expenses up to $10 million in connection with the consummation of the Mergers and the other transactions contemplated by the Merger Agreement.

On July 21, 2023, pursuant to the Second Merger Amendment, Infinite Reality deposited a Monthly Extension Fee of $0.2 million directly into the Trust Account on behalf of the Company, bringing the balance of the Contribution outstanding to $1.0 million. Any monthly extension payment deposited into the Trust Account by Infinite Reality is nonreimbursable by the Company or the Sponsor.

25

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this Report to “we,” “us” or the “Company” refer to Newbury Street Acquisition Corporation. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Newbury Street Acquisition Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Report. Certain capitalized terms used but not defined in the below discussion and elsewhere in this Report have the meanings ascribed to them in the footnotes to the accompanying financial statements included as part of this Report.

Cautionary Note Regarding Forward-Looking Statements

All statements other than statements of historical fact included in this Report including, without limitation, statements under this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our financial position, business strategy and the plans and objectives of management for future operations, are forward- looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

Overview

We are a blank check company formed under the laws of the State of Delaware on November 6, 2020 for the purpose of effecting a Business Combination. We intend to effectuate the Company’s Business Combination using cash from the proceeds of the Public Offering and the sale of the Private Units, the Company’s capital stock, debt or a combination of cash, stock and debt.

All activity through June 30, 2023 related to the Company’s formation, Public Offering, and search for and consummation of an initial Business Combination.

Factors That May Adversely Affect the Company’s Results of Operations

The Company’s results of operations and the Company’s ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond the Company’s control. The Company’s business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s business and the Company’s ability to complete an initial Business Combination.

Infinite Reality Business Combination

On December 12, 2022, the Company entered into the Merger Agreement by and among the Company, Pubco, Purchaser Merger Sub, Infinite Reality Merger Sub and Infinite Reality. Pursuant to the terms of the Merger Agreement, (i) Purchaser Merger Sub will merge with and into the Company, with the Company continuing as the surviving entity and (ii) Infinite Reality Merger Sub will merge with and into Infinite Reality, with Infinite Reality continuing as the surviving entity. Following the Mergers, the Company and Infinite Reality will become direct wholly-owned subsidiaries of Pubco, and Pubco will become a publicly traded company.

On May 15, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and Infinite Reality entered into the first amendment to the Merger Agreement (the “First Merger Amendment”) to provide for (i) a revised definition of “fully diluted shares”, (ii) the removal of Section 7.2(b) of the Merger Agreement (Minimum Cash Condition) in its entirety; and (iii) the addition of a new Section 6.23 providing for the payment by the Company of all transaction expenses up to $10 million in connection with the consummation of the Mergers and the other transactions contemplated by the Merger Agreement.

26

On July 21, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and the Infinite Reality entered into the Second Merger Amendment to provide for the addition of a new Section 6.24 pursuant to which Infinite Reality agrees to pay a “Monthly Extension Fee” of $0.2 million per month directly into the Trust Account on behalf of the Company, on or before the date when such payment becomes due, until the completion of the Mergers. In addition, if the Merger Agreement is terminated for any reason other than a breach by the Company, Infinite Reality agrees to pay all expenses of the Company incurred after March 31, 2023, provided that in no event shall such payment exceed $3 million (inclusive of all Monthly Extension Fees paid). In the event that the Mergers are consummated, the Company agrees to pay for all transaction expenses up to $10 million in connection with the consummation of the Mergers and the other transactions contemplated by the Merger Agreement.

For a full description of the First Merger Amendment and the Second Merger Amendment, please see the Company’s Current Reports on Form 8-K, as filed with the SEC on May 16, 2023 and July 27, 2023, respectively.

Results of Operations

The Company has neither engaged in any operations nor generated any revenues to date. The Company’s only activities from commencement of operations through June 30, 2023 were related to the Company’s formation and the Public Offering, and subsequent to the Public Offering, identifying a target company for Business Combination, and subsequent to entering into the Merger Agreement, pursuing the completion of the Infinite Reality Business Combination. The Company does not expect to generate any operating revenues until after the completion of its Business Combination. The Company generates non-operating income in the form of interest income or dividend income on marketable securities held in the Trust Account. The Company incurs expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses for due diligence related to the search for potential target companies.

For the three months ended June 30, 2023, the Company had a net loss of approximately $0.08 million, which consisted of dividend income of approximately $0.51 million and change in fair value of warrant liabilities of approximately $0.03 million, franchise tax expense of approximately $0.05 million, income tax expense of approximately $0.13 million and operating costs of approximately $0.38 million.

For the three months ended June 30, 2022, the Company had a net loss of approximately $0.07 million, which consisted of dividend income of approximately $0.17 million and change in fair value of warrant liabilities of approximately $0.03 million, offset by franchise tax expense of approximately $0.05 million, income tax expense of $4,066 and operating costs of approximately $0.22 million.

For the six months ended June 30, 2023, the Company had a net profit of approximately $0.32 million, which consisted of dividend income of $1.89 million, change in fair value of warrant liabilities of approximately $0.02 million and offset by franchise tax expense of approximately $0.10 million and operating costs of approximately $0.96 million.

For the six months ended June 30, 2022, the Company had a net loss of approximately $0.31 million, which consisted of dividend income of approximately $0.19 million, change in fair value of warrant liabilities of approximately $0.10 million and other income of $5,000, offset by franchise tax expense of approximately $0.10 million, income tax expense of $4,066 and operating costs of approximately $0.50 million.

Liquidity and Capital Resources

As of June 30, 2023, the Company had approximately $0.01 million in cash and no cash equivalents.

Until the consummation of the Public Offering, the Company’s only source of liquidity was an initial purchase of common stock by the Sponsor and loans from its Sponsor.

On March 25, 2021, the Company’s consummated the Public Offering of 12,000,000 units, at a price of $10.00 per unit, generating gross proceeds of $120.00 million. Simultaneously with the closing of the Public Offering, the Company consummated the sale of 390,000 Private Units at a price of $10.00 per Private Unit in a private placement to Sponsor and EBC, generating gross proceeds of $3.90 million. On March 30, 2021, the underwriters exercised the over-allotment option in part and purchased an additional 843,937 units, generating gross proceeds of approximately $8.44 million. In connection with the underwriters’ partial exercise of the over-

27

allotment option, the Company sold an additional 16,879 Private Units at a price of $10.00 per private unit in a private placement to Sponsor and EBC, generating gross proceeds of approximately $0.17 million.

Following the Public Offering and the private placement, a total of approximately $128.44 million was placed in the Trust Account. The Company incurred approximately $3.00 million in transaction costs, including approximately $2.57 million of underwriting fees and approximately $0.43 million of other offering costs.

As of June 30, 2023, the Company had assets held in the Trust Account of approximately $53.33 million.In connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders, approximately $78.8 million was removed from the Trust Account on April 3, 2023. As of June 30, 2023, the Company had approximately $53.33 million in its Trust Account. The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing income earned on the Trust Account, to complete its Business Combination. To the extent that the Company’s capital stock or debt is used, in whole or in part, as consideration to complete its Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue the Company’s growth strategies.

As of June 30, 2023, the Company had cash of approximately $0.01 million outside of the Trust Account. The Company intends to use the funds held outside the Trust Account and any proceeds from borrowings primarily to perform business due diligence on prospective target businesses, including for the Infinite Reality Business Combination, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Company’s Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company may repay such loaned amounts out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from the Company’s Trust Account would be used for such repayment. Up to $1.50 million of such loans may be convertible into units at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Units.

On May 3, 2022, the Company issued a promissory note for up to approximately $0.4 million (the “Note”) to the Sponsor. The first drawdown was on May 24, 2022 of approximately $0.23 million. On August 30, 2022, September 6, 2022 and September 21, 2022, there were additional drawdowns of approximately $0.04 million, $0.11 million and $0.02 million, respectively. The Note is non-interest bearing and the Company must make drawdown requests in amounts no less than $10,000 unless otherwise agreed upon by the parties. The principal balance of the Note is payable on the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective (such date, the “Maturity Date”).

The Company, pursuant to the Note, may at any time prior to payment in full of the principal balance of the Note, elect to convert all or any portion of the unpaid principal balance of the Note into units at a conversion price of $10.00 per unit.

However, on March 15, 2023, the Company amended and restated the Note (the “Amended Note”) in its entirety to (1) increase the principal amount thereunder from $0.4 million to $0.9 million and (2) remove the right of the holder of the Amended Note to convert all or any portion of the unpaid principal balance of the note into the Company’s units and related registration rights for such units (including underlying securities). The Amended Note is non-interest bearing and is payable on the earlier of (i) the date on which the Company consummates its initial Business Combination or (ii) the date that the winding up of the Company is effective.

On March 22, 2023, the Company amended and restated the Amended Note (the “Second Amended Note”) to increase the principal amount of up to $0.9 million to up to $2.1 million, pursuant to which the sponsor agreed to loan to the Company up to $2.1 million.

In April 2023, $49,140 was drawn down under the Second Amended Note. In May 2023, an additional aggregate of $221,449 was drawn down under the Second Amended Note. In June 2023, an additional aggregate of $83,500 was drawn down, and an aggregate of $57,335 was refunded, under the Second Amended Note.

28

At June 30, 2023 and December 31, 2022, approximately $0.72 million and $0.40 million were outstanding under the Second Amended Note, respectively.

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) Subtopic 205-40, “Presentation of Financial Statements — Going Concern”, the Company has until September 25, 2023 to consummate a Business Combination. If a Business Combination is not consummated by this date and an extension not obtained, there will be a mandatory liquidation and subsequent dissolution of the Company. Although the Company intends to consummate a Business Combination on or before September 25, 2023, it is uncertain whether the Company will be able to consummate a Business Combination by this time. Management has determined that the mandatory liquidation, should a Business Combination not occur and an extension is not obtained, and potential subsequent dissolution, as well as the potential for the Company to have insufficient funds available to operate its business prior to a Business Combination, raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 25, 2023.

Extension Loan

In connection with the approval of the Extension Proposal (as defined below), the Sponsor or its designees have agreed to contribute to the Company as a note (i) the lesser of (a) an aggregate of $600,000 or (b) $0.04 for each public share on a monthly basis that is not redeemed in connection with the Extension Amendment for the portion of the Extension ending on June 23, 2023 (the “Initial Contribution”); plus, (ii) an aggregate of $200,000 per month (commencing on June 23, 2023 and on the 23rd day of each subsequent month) until the charter extension date (each, an “Extension Period”), or portion thereof, that is needed to complete an initial Business Combination (each monthly payment, a “Monthly Extension Fee” and, together with the Initial Contribution, the “Contribution”), which amount will be deposited into the Trust Account. Accordingly, the amount deposited per share depends on the number of public shares that remain outstanding after the redemption and the length of the extension period that will be needed to complete an initial Business Combination.

On March 24, 2023, the Sponsor made the Initial Contribution of $600,000, which was deposited into the Trust Account.

On June 26, 2023, a Monthly Extension Fee of $200,000 was deposited into the Trust Account, which was comprised of a $100,000 payment from the Sponsor and a $100,000 payment from Infinite Reality.

On July 21, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and the Infinite Reality entered into the Second Merger Amendment pursuant to which Infinite Reality agreed to pay the Monthly Extension Fee of $200,000 per month directly into the Trust Account on behalf of the Company, on or before the date when such payment becomes due, until the completion of the Mergers.

On July 21, 2023, Infinite Reality deposited a Monthly Extension Fee of $200,000 directly into the Trust Account on behalf of the Company, bringing the balance of the Contribution outstanding to $1.0 million.

Off-Balance Sheet Arrangements

The Company had no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2023. The Company does not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. The Company has not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

The Company does not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than described below.

29

Business Combination Marketing Agreement

The Company has engaged EBC as an advisor in connection with its Business Combination to assist it in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist it with its press releases and public filings in connection with the Business Combination. The Company will pay EBC a cash fee of up to $4.2 million for such services upon the consummation of its initial Business Combination (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at its sole discretion to other Financial Industry Regulatory Authority members that assist us in identifying or consummating an initial Business Combination. The Company will also pay EBC a cash fee of up to 1% of the gross proceeds from the Public Offering as a fee for introducing the Company to target companies for an initial Business Combination.

Registration Rights

Pursuant to a registration rights agreement entered into on March 22, 2021, the holders of the Founder Shares and Representative Shares, as well as the holders of the Private Units (and underlying securities) and any units issued in payment of Working Capital Loans made to us (and underlying securities) are entitled to registration rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities.

The holders of a majority of the Representative Shares, Private Units and units issued in payment of Working Capital Loans made to us (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. Notwithstanding anything to the contrary, EBC. may only make a demand on one occasion and only during the five-year period beginning on the effective date of the Registration Statement. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to consummation of a Business Combination; provided, however, that EBC may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the Registration Statement.

The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the Public Offering to purchase up to 1,800,000 additional units to cover over-allotments, if any, at the public offering price less the underwriting discounts and commissions.

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $2.40 million in the aggregate, paid at the closing of the Public Offering. On March 30, 2021, the underwriters partially exercised their over-allotment option to purchase an additional 843,937 units at $10.00 per unit. In connection with the underwriters’ partial exercise of the over-allotment option on March 30, 2021, the underwriters were paid an additional cash underwriting fee of approximately $0.17 million.

Administrative Support Agreement

The Company has agreed to pay the Sponsor a total of up to $0.01 million per month, from the effective date of the Registration Statement, for office space, utilities and secretarial and administrative support. Services will terminate upon the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company. For the six months ended June 30, 2023, the Company has accrued $0.06 million for these services. For the six months ended June 30, 2022, the Company paid $0.04 million and accrued $0.02 million for these services. These amounts are included in the operating costs on accompanying condensed statements of operations.

30

Critical Accounting Estimates

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. The Company has identified the following as its critical accounting policies:

Net Profit (Loss) Per Share of Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net profit (loss) per share of common stock is computed by dividing net profit (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. The Company applies the two-class method in calculating earnings per share. The calculation of diluted profit (loss) per share of common stock does not consider the effect of the warrants issued in connection with the Public Offering since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

Warrants

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Subtopic 815-15.

The Company accounts for the warrants, as either equity or liability-classified instruments based on an assessment of the specific terms of the warrants and the applicable authoritative guidance in FASB ASC Topic 815, Derivatives and Hedging. The assessment considers whether the Warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to its own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of its control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance of the warrants and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, such warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, such warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of liability-classified warrants are recognized as a non-cash gain or loss on the statements of operations.

The Private Warrants are recognized as derivative liabilities in accordance with ASC Subtopic 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Private Warrants was initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Warrants have been estimated using a Monte Carlo simulation model each measurement date.

31

Common Stock Subject to Possible Redemption

The Company accounts for the common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as stockholders’ equity. The Company’s shares of common stock that were sold as part of units in the Public Offering feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events.

On March 3, 2023, the Company filed a definitive proxy statement for a special meeting on March 21, 2023 (the “Special Meeting”) to seek approval from its stockholders to amend the Company’s Second Amended and Restated Certificate of Incorporation to extend the date by which the Company is required to complete its initial Business Combination from March 25, 2023 to September 25, 2023 (the “Extension Proposal”) and to approve the adjournment of the Special Meeting to a later date or dates, if necessary or convenient, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Proposal (the “Adjournment Proposal”). The Extension Proposal and Adjournment Proposal were approved on March 21, 2023.

In connection with approval of the Extension Proposal, the holders of 7,744,085 shares of common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.17 per share, for an aggregate redemption amount of approximately $78.8 million. As a result, on April 3, 2023, approximately $78.8 million was removed from the Company’s Trust Account to pay such holders, following which, 5,099,852 shares of common stock subject to redemption, remain outstanding.

Recent Accounting Pronouncements

In August 2020, FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments.

The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2023, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

32

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including its principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

As required by Rules 13a-15f and 15d-15 under the Exchange Act, our principal executive officer and principal financial officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2023. Based upon their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of June 30, 2023.

Our internal control over financial reporting did not result in the application of complex financial instruments and complex accounting matters issued in March 2021, which, due to its impact on our financial statements, we determined to be a material weakness.

The Company restated its financial statements included in its Quarterly Reports on Form 10-Q for the quarters ended June 30, 2021, and March 31, 2021, and Current Report on Form 8-K as of March 25, 2021, to reclassify all the Company’s common stock subject to possible redemption in temporary equity.

Changes in Internal Control over Financial Reporting

Other than as described herein, there was no change in our internal control over financial reporting that occurred during the quarterly period ended June 30, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Management identified a material weakness in internal controls related to application of complex financial instruments and complex accounting matters as described above. To respond to this material weakness, we have devoted, and plan to continue to devote, significant effort and resources to the remediation and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance our system of evaluating and implementing the accounting standards that apply to our financial statements, including through enhanced analyses by our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

33

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

To the knowledge of our management team, there is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

Item 1A. Risk Factors.

Not required for a smaller reporting company. However, as of the date of this Report, there have been no material changes with respect to those risk factors previously disclosed in the Company’s filings with the SEC.

34

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

For a description of the use of the proceeds generated in our Public Offering, see Part II, Item 2 of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021. There has been no material change in the planned use of the proceeds from the Company’s Public Offering and private placement as is described in the Company’s final prospectus, dated March 25, 2021.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None.

35

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Report.

No.	Description of Exhibit
2.1	Second Amendment to Agreement and Plan of Merger, dated July 21, 2023. (incorporated by reference to Exhibit 2.1 of the Company’s Form 8-K filed with the SEC on July 27, 2023)
31.1*	Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*	Inline XBRL Instance Document
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*	Inline XBRL Taxonomy Extension Schema Document
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*Filed herewith.

**Furnished.

36

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NEWBURY STREET ACQUISITION CORPORATION
Date: August 14, 2023	By:	/s/ Thomas Bushey
	Name:	Thomas Bushey
	Title:	Chief Executive Officer
		(Principal Executive Officer)
Date: August 14, 2023	By:	/s/ Kenneth King
	Name:	Kenneth King
	Title:	Chief Financial Officer
		(Principal Accounting and Financial Officer)

37

EX-31.1

Exhibit 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas Bushey, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Newbury Street Acquisition Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 14, 2023	By:	/s/ Thomas Bushey
		Thomas Bushey
		Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kenneth King, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Newbury Street Acquisition Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 14, 2023	By:	/s/ Kenneth King
		Kenneth King
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Newbury Street Acquisition Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas Bushey, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)   the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 14, 2023
	/s/ Thomas Bushey
	Name:	Thomas Bushey
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Newbury Street Acquisition Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kenneth King, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)   the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 14, 2023
	/s/ Kenneth King
	Name:	Kenneth King
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 14, 2023
Document Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-40251
Entity Registrant Name	NEWBURY STREET ACQUISITION CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3985188
Entity Address, Address Line One	121 High Street, Floor 3
Entity Address, City or Town	Boston
Entity Address State Or Province	MA
Entity Address, Postal Zip Code	02110
City Area Code	617
Local Phone Number	893-3057
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		8,917,715
Entity Central Index Key	0001831978
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Units, each consisting of one share of Common Stock and one-half of one Redeemable Warrant
Document Entity Information
Title of 12(b) Security	Units, each consisting of one share of Common Stock and one-half of one Redeemable Warrant
Trading Symbol	NBSTU
Security Exchange Name	NASDAQ
Common Stock
Document Entity Information
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	NBST
Security Exchange Name	NASDAQ
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock
Document Entity Information
Title of 12(b) Security	Redeemable Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share
Trading Symbol	NBSTW
Security Exchange Name	NASDAQ

XML

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current Assets
Cash	$ 14,472	$ 83,643
Prepaid expenses - current		47,625
Total Current Assets	14,472	131,268
Cash held in Trust Account	53,327,162	129,951,121
Total Assets	53,341,634	130,082,389
Current Liabilities
Accrued expenses	2,285,752	1,767,679
Excise duty payable	787,706
Income tax payable	488,260	413,919
Franchise tax payable	19,949	45,816
Related party payable	$ 480	$ 480
Other Liability, Current, Related Party, Type [Extensible Enumeration]	us-gaap:RelatedPartyMember	us-gaap:RelatedPartyMember
Promissory note - related party	$ 721,327	$ 399,903
Notes Payable, Current, Related Party, Type [Extensible Enumeration]	us-gaap:RelatedPartyMember	us-gaap:RelatedPartyMember
Extension loan	$ 700,000
Derivative warrant liabilities	38,654	$ 14,241
Total Current Liabilities	5,042,128	2,642,038
Commitments and Contingencies
Common stock subject to possible redemption; 5,099,852 shares as of June 30, 2023, and 12,843,937 shares as of December 31, 2022, respectively, at redemption value	52,738,744	129,951,121
STOCKHOLDERS' DEFICIT
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 3,817,863 shares issued and outstanding, excluding 5,099,852 shares as of June 30, 2023, and 12,843,937 shares as of December 31, 2022, respectively, subject to possible redemption	382	382
Additional paid-in capital	100,000	0
Accumulated deficit	(4,539,620)	(2,511,152)
Total Stockholders' Deficit	(4,439,238)	(2,510,770)
Total Liabilities, Common stock subject to possible redemption and Stockholders' Deficit	$ 53,341,634	$ 130,082,389

XML

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022	Mar. 25, 2021
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common shares, par value, (per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, shares authorized	100,000,000	100,000,000
Common shares, shares issued	3,817,863	3,817,863
Common shares, shares outstanding	3,817,863	3,817,863
Common stock subject to possible redemption	5,099,852	12,843,937
Common stock subject to possible redemption
Common stock subject to possible redemption	5,099,852	12,843,937
Common stock Not subject to possible redemption
Common shares, shares issued	3,817,863	3,817,863
Common shares, shares outstanding	3,817,863

XML

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Formation and operating costs	$ 380,474	$ 219,959	$ 956,135	$ 497,615
Franchise tax expense	50,000	50,000	100,000	100,000
Loss from operations	(430,474)	(269,959)	(1,056,135)	(597,615)
Other income:
Change in fair value of derivative warrant liabilities	(29,519)	28,482	(24,413)	95,617
Dividend income	507,720	173,437	1,886,450	186,371
Other income				5,000
Profit (loss) before provision for income taxes	47,727	(68,040)	805,902	(310,627)
Income tax expense	(125,049)	(4,066)	(488,418)	(4,066)
Net (loss) profit	$ (77,322)	$ (72,106)	$ 317,484	$ (314,693)
Redeemable common stock
Other income:
Weighted average shares outstanding, basic	5,099,852	12,843,937	8,541,668	12,843,937
Weighted average shares outstanding, diluted	5,099,852	12,843,937	8,541,668	12,843,937
Basic net (loss) profit per share	$ 0.00	$ 0.00	$ 0.03	$ (0.02)
Diluted net (loss) profit per share	$ 0.00	$ 0.00	$ 0.03	$ (0.02)
Non-redeemable common stock
Other income:
Weighted average shares outstanding, basic	3,817,863	3,817,863	3,817,863	3,817,863
Weighted average shares outstanding, diluted	3,817,863	3,817,863	3,817,863	3,817,863
Basic net (loss) profit per share	$ 0.00	$ 0.00	$ 0.03	$ (0.02)
Diluted net (loss) profit per share	$ 0.00	$ 0.00	$ 0.03	$ (0.02)

XML

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2021	$ 382	$ 882,581	$ (594,303)	$ 288,660
Balance at the beginning (in shares) at Dec. 31, 2021	3,817,863
Increase (Decrease) in Stockholders' Equity
Net profit (loss)	$ 0	0	(242,587)	(242,587)
Balance at the end at Mar. 31, 2022	$ 382	882,581	(836,890)	46,073
Balance at the end (in shares) at Mar. 31, 2022	3,817,863
Balance at the beginning at Dec. 31, 2021	$ 382	882,581	(594,303)	288,660
Balance at the beginning (in shares) at Dec. 31, 2021	3,817,863
Increase (Decrease) in Stockholders' Equity
Net profit (loss)				(314,693)
Balance at the end at Jun. 30, 2022	$ 382	696,252	(908,996)	(212,362)
Balance at the end (in shares) at Jun. 30, 2022	3,817,863
Balance at the beginning at Mar. 31, 2022	$ 382	882,581	(836,890)	46,073
Balance at the beginning (in shares) at Mar. 31, 2022	3,817,863
Increase (Decrease) in Stockholders' Equity
Accretion for common stock to redemption amount	$ 0	(186,329)	0	(186,329)
Net profit (loss)	0	0	(72,106)	(72,106)
Balance at the end at Jun. 30, 2022	$ 382	696,252	(908,996)	(212,362)
Balance at the end (in shares) at Jun. 30, 2022	3,817,863
Balance at the beginning at Dec. 31, 2022	$ 382	0	(2,511,152)	(2,510,770)
Balance at the beginning (in shares) at Dec. 31, 2022	3,817,863
Increase (Decrease) in Stockholders' Equity
Accretion for common stock to redemption amount	$ 0	0	(1,105,575)	(1,105,575)
Excise duty in connection with redemption of redeemable shares	0	0	(787,706)	(787,706)
Net profit (loss)	0	0	394,806	394,806
Balance at the end at Mar. 31, 2023	$ 382	0	(4,009,627)	(4,009,245)
Balance at the end (in shares) at Mar. 31, 2023	3,817,863
Balance at the beginning at Dec. 31, 2022	$ 382	0	(2,511,152)	(2,510,770)
Balance at the beginning (in shares) at Dec. 31, 2022	3,817,863
Increase (Decrease) in Stockholders' Equity
Net profit (loss)				317,484
Balance at the end at Jun. 30, 2023	$ 382	100,000	(4,539,620)	(4,439,238)
Balance at the end (in shares) at Jun. 30, 2023	3,817,863
Balance at the beginning at Mar. 31, 2023	$ 382	0	(4,009,627)	(4,009,245)
Balance at the beginning (in shares) at Mar. 31, 2023	3,817,863
Increase (Decrease) in Stockholders' Equity
Accretion for common stock to redemption amount	$ 0	0	(452,671)	(452,671)
Monthly Extension Fee Provided by Infinite Reality	0	100,000	0	100,000
Net profit (loss)	0	0	(77,322)	(77,322)
Balance at the end at Jun. 30, 2023	$ 382	$ 100,000	$ (4,539,620)	$ (4,439,238)
Balance at the end (in shares) at Jun. 30, 2023	3,817,863

XML

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net profit (loss)	$ 317,484	$ (314,693)
Adjustments to reconcile net profit (loss) to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	24,413	(95,617)
Dividend earned from Trust Account	(1,886,450)	(186,371)
Changes in operating assets and liabilities:
Prepaid expenses - current	47,625	50,691
Prepaid expenses - non-current		47,625
Accrued expenses	518,073	(1,367)
Franchise tax payable	(25,867)	(169,421)
Income tax payable	74,341	4,066
Related party payable		480
Net cash used in operating activities	(930,381)	(664,607)
Cash Flows from Investing Activities:
Deposit into Trust Account for extension	(800,000)
Transfer from Trust Account	539,786	9,500
Cash withdrawn from Trust account in connection with redemption	78,770,623
Net cash (used in) provided by investing activities	78,510,409	9,500
Cash Flows from Financing Activities:
Proceeds from promissory note - related party	321,424	230,367
Proceeds from extension loan - related party	700,000
Proceeds from Infinite Reality for extension	100,000
Payment for Redemption	(78,770,623)
Net cash provided by financing activities	(77,649,199)	230,367
Net Change in Cash	(69,171)	(424,740)
Cash - Beginning of period	83,643	435,936
Cash - End of period	14,472	11,196
Non-cash investing and financing activities:
Accretion for common stock to redemption amount	1,558,246	$ 186,329
Excise tax payable	$ 787,706

XML

ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS

6 Months Ended

Jun. 30, 2023

ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS

ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS

Newbury Street Acquisition Corporation (the “Company”) was incorporated in Delaware on November 6, 2020. The Company is a blank check formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

While the Company may pursue a Business Combination target in any business or industry, the Company intends to focus its search on a technology business in the consumer internet or media space, including sports and entertainment verticals. In particular, the Company shall focus on disruptive, high growth companies with a global ambition that take advantage of: (a) the rise of new consumer behaviors driven by the internet or new technologies, or (b) paradigm shifts in media, sports and entertainment that give rise to disruptive new entrants here to stay for the coming decades. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2023, the Company had no operating activity. During the period from January 15, 2021 (commencement of operations) to June 30, 2023, the Company’s activity up to the Public Offering related to the Company’s formation and Public Offering, which is described below, and subsequent to the Public Offering, the search for and consummation of a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income or dividend income derived from the funds deposited in Trust Account. The Company has selected December 31 as its fiscal year end.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account, excluding taxes payable on the income earned on the Trust Account at the time of the Company’s signing a definitive agreement in connection with its initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target business or assets sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide the public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata income earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption are recorded at redemption value and are classified as temporary equity upon the completion of the Public Offering in accordance with the ASC Topic 480 “Distinguishing Liabilities from Equity.”

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Second Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares and any Public Shares purchased during or after the Public Offering (a) in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Second Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.

The Company initially had up to 24 months from the closing of the Public Offering to March 25, 2023 to complete a Business Combination, which was extended to September 25, 2023 at the special meeting of the Company’s stockholders on March 21, 2023. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including income earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $0.10 million of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.00).

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act.

Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Merger Agreement

On December 12, 2022, the Company, entered into the Merger Agreement by and among (i) the Company, (ii) Pubco, (iii) Purchaser Merger Sub, (iv) Company Merger Sub, and (v) Infinite Reality.

Pursuant to the terms of the Merger Agreement, (i) Purchaser Merger Sub will merge with and into the Company, with the Company continuing as the surviving entity, (ii) Company Merger Sub will merge with and into Infinite Reality, with the Infinite Reality continuing as the surviving entity, and (iii) following the Mergers, the Company and Infinite Reality will become direct wholly-owned subsidiaries of Pubco, and Pubco will become a publicly traded company.

On May 15, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and Infinite Reality entered into the first amendment to the Merger Agreement (the “First Merger Amendment”) to provide for (i) a revised definition of "fully diluted shares", (ii) the removal of Section 7.2(b) of the Merger Agreement (Minimum Cash Condition) in its entirety; and (iii) the addition of a new Section 6.23 providing for the payment by the Company of all transaction expenses up to $10 million in connection with the consummation of the Mergers and the other transactions contemplated by the Merger Agreement.

On July 21, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and Infinite Reality entered into a second amendment to the Merger Agreement (the “Second Merger Amendment”) to provide for the addition of a new Section 6.24 pursuant to which Infinite Reality agrees to pay a “Monthly Extension Fee” of $200,000 per month directly into the Trust Account on behalf of the Company, on or before the date when such payment becomes due, until the completion of the Mergers. In addition, if the Merger Agreement is terminated for any reason other than a breach by the Company, Infinite Reality agrees to pay all expenses of the Company incurred after March 31, 2023, provided that in no event shall such payment exceed $3,000,000 (inclusive of all Monthly Extension Fees paid). In the event that the Mergers are consummated, the Company agrees to pay for all transaction expenses up to $10,000,000 in connection with the consummation of the Mergers and the other transactions contemplated by the Merger Agreement.

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)

Stockholder Extension Meeting

On March 3, 2023, the Company filed a definitive proxy statement for a special meeting on March 21, 2023 (the “Special Meeting”) to seek approval from its stockholders to amend the Second Amended and Restated Certificate of Incorporation to further extend the date by which the Company is required to complete its initial Business Combination from March 25, 2023 to September 25, 2023 (the “Extension Proposal”) and to approve the adjournment of the Special Meeting to a later date or dates, if necessary or convenient, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Proposal (the “Adjournment Proposal”). The Extension Proposal and Adjournment Proposal were approved on March 21, 2023.

In connection with approval of the Extension Proposal, the holders of 7,744,085 shares of common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.17 per share, for an aggregate redemption amount of approximately $78.8 million.

On March 23, 2023, the Company filed an amendment to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to extend the date by which the Company has to consummate a Business Combination from March 25, 2023 to September 25, 2023.

Additionally, in connection with the approval of the Extension Proposal, the Sponsor or its designees have agreed to contribute to the Company as a note (i) the lesser of (a) an aggregate of $600,000 or (b) $0.04 for each public share on a monthly basis that is not redeemed in connection with the Extension Amendment for the portion of the Extension ending on June 23, 2023 (the “Initial Contribution”); plus, (ii) an aggregate of $200,000 per month (commencing on June 23, 2023 and on the 23rd day of each subsequent month) until the charter extension date (each, an “Extension Period”), or portion thereof, that is needed to complete an initial Business.

Combination (each monthly payment, a “Monthly Extension Fee” and, together with the Initial Contribution, the “Contribution”), which amount will be deposited into the Trust Account. Accordingly, the amount deposited per share depends on the number of public shares that remain outstanding after the redemption and the length of the extension period that will be needed to complete an initial Business Combination.

On March 24, 2023, the Sponsor made the Initial Contribution of $600,000, which was deposited into the Trust Account.

On June 26, 2023, a Monthly Extension Fee of $200,000 was deposited into the Trust Account, which was comprised of a $100,000 payment from the Sponsor and a $100,000 payment from Infinite Reality (Refer to Note 6).

On July 21, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and the Infinite Reality entered into the Second Merger Amendment pursuant to which Infinite Reality agreed to pay the Monthly Extension Fee of $200,000 per month directly into the Trust Account on behalf of the Company, on or before the date when such payment becomes due, until the completion of the Mergers.

On July 21, 2023, Infinite Reality deposited a Monthly Extension Fee of $200,000 directly into the Trust Account on behalf of the Company, bringing the balance of the Contribution outstanding to $1.0 million.

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)

Liquidity and Going Concern

As of June 30, 2023, the Company had approximately $0.01 million in its operating bank account, approximately $53.33 million of cash held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and a working capital deficiency of approximately $5.13 million. In connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders, approximately $78.8 million was removed from the Trust Account on April 3, 2023. As of June 30, 2023, the Company had approximately $53.33 million in its Trust Account.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account performing due diligence on prospective target businesses, including for the Infinite Reality Business Combination, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through September 25, 2023, the date that the Company will be required to cease all operations, except for the purpose of winding up, if a Business Combination is not consummated. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

XML

SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2023

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the GAAP for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 31, 2023. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2023 and December 31, 2022, the Company did not have any cash equivalents, outside of funds held in the Trust Account.

As of June 30, 2023 and December 31, 2022, the Company had cash of approximately $0.01 million and $0.08 million, respectively, outside of funds held in the Trust Account.

Cash Held in Trust Account

At June 30, 2023 and December 31, 2022, the Company had approximately $53.33 million and $129.95 million, respectively, of assets held in the Trust Account in an interest-bearing demand deposit account and in Treasury Bills. respectively.

On April 3, 2023, approximately $78.8 million was removed from the Trust Account in connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders subsequent to the approval of the Extension Proposal.

On April 11, 2023, the Company liquidated the funds held in the Trust Account and instead holds the funds in the Trust Account in an interest bearing demand deposit account until the earlier of the consummation of our Business Combination or the Company’s liquidation.

On June 26, 2023, a Monthly Extension Fee of $200,000 was deposited into the Trust Account, which was comprised of a $100,000 payment from the Sponsor and a $100,000 payment from Infinite Reality. The monthly extension payment of $100,000 deposited into the Trust Account by Infinite Reality is non-reimbursable by the Company or the Sponsor.

On July 21, 2023, pursuant to the Second Merger Amendment, Infinite Reality deposited a Monthly Extension Fee of $200,000 directly into the Trust Account on behalf of the Company, bringing the balance of the Contribution outstanding to $1.0 million. Any monthly extension payment deposited into the Trust Account by Infinite Reality is non-reimbursable by the Company or the Sponsor.

Common Stock Subject to Possible Redemption

All of the 12,843,937 shares of common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation if there is a stockholder vote or tender offer in connection with the Business Combination. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC Topic 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC Topic 480.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of common stock are affected by charges against additional paid-in capital and accumulated deficit.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Common Stock Subject to Possible Redemption (Continued)

As of June 30, 2023 and December 31, 2022, the shares of common stock subject to possible redemption and included as temporary equity were as follows:

	As of		As of
	June 30, 2023		December 31, 2022
Gross proceeds	$	129,951,121	$	128,439,370
Plus:
Accretion of carrying value to redemption value		1,558,248		1,511,751
Stockholders redemptions		(78,770,623)		—
Contingently redeemable common stock	$	52,738,744	$	129,951,121

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are charged against the carrying value of common stock or stockholders’ deficit based on the relative value of the shares of common stock and the warrants, to the proceeds received from the Units sold upon the completion of the Public Offering. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Public Offering that were directly related to the Public Offering. The Company incurred offering costs amounting to $3.00 million as a result of the Public Offering, consisting of $2.57 million of cash underwriting discount and $0.43 million of other offering costs. As such, the Company recorded $2.90 million of offering costs as a reduction of temporary equity, $0.10 million of offering costs as a reduction of permanent equity and $454 of offering cost as reduction in the statement of operations.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the federal depository insurance coverage of $0.25 million. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

● Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

● Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

● Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

As of June 30, 2023 and December 31, 2022, the carrying values of cash, prepaid expenses, accrued expenses, franchise tax payable approximated their fair values due to the short-term nature of the instruments.

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Subtopic 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The 203,440 Private Warrants are recognized as derivative liabilities in accordance with ASC Subtopic 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the Private Warrants was initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Warrants have been estimated using a Monte Carlo simulation model each measurement date.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Net (Loss) Profit Per Share of Common Stock

The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net  (loss) profit per share of common stock is computed by dividing the pro rata net  (loss) profit between the shares of common stock subject to redemption and the shares of common stock not subject to redemption by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted (loss) profit per share of common stock does not consider the effect of the warrants issued in connection with the Public Offering since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 6,625,409 shares of common stock in the aggregate.

	Three Months Ended		Three Months Ended		Six Months Ended		Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Common stock subject to possible redemption
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$	(44,219)	$	(55,584)	$	219,413	$	(242,585)
Denominator:
Weighted average shares outstanding, redeemable common stock		5,099,852		12,843,937		8,541,668		12,843,937
Basic and diluted net (loss) profit per share, redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)
Non-redeemable common stock
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$	(33,103)	$	(16,522)	$	98,071	$	(72,108)
Denominator:
Weighted average shares outstanding, non-redeemable common stock		3,817,863		3,817,863		3,817,863		3,817,863
Basic and diluted net (loss) profit per share, non-redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Income Taxes

The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.

The Company recorded income tax expense of $0.49 million based on activities through June 30, 2023, primarily as a result of investment income, partially offset by deductible expenses. The Company's year to date effective tax rate for the second quarter ended June 30, 2023 was 60.61% compared to (1.31%) in the year to date second quarter ended June 30, 2022. The Company's effective rate for the standalone second quarter ended June 30, 2023 was 262% compared to 5.98% in the standalone second quarter ended June 30, 2022. The 2023 year to date effective rate of 60.61% differs from the statutory tax rate of 21% mainly due to permanent nondeductible GAAP expenses, state income taxes and change in the valuation allowance. The standalone second quarter ended June 30, 2023 effective rate of 262% differs from the statutory tax rate of 21% mainly due to permanent non-deductible GAAP expenses, state income taxes and change in the valuation allowance.

The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.

The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying statement of operations. As of June 30, 2023, the Company does not have uncertain tax positions or interest and penalties related to uncertain tax positions.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was enacted into law. Among other changes to the tax code, the act imposes a 1% excise tax on certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022. The stock buyback tax may be applicable to certain SPAC redemptions, including in connection with a SPAC’s business combination. For purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, a number of exceptions to the stock buyback tax are available including exceptions to certain reorganizations; however, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

Income Taxes (Continued)

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension a vote by stockholders to extend the period of time to complete the Business Combination (the “extension vote”) or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. As of June 30, 2023, $0.79 million was incurred by the Company as excise tax expense in connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders.

The IRS issued Notice 2023-3 (Initial guidance regarding the application of the excise tax on repurchases of corporate stock). The notice defines stock redemptions per Internal Revenue Code (IRC) section 317(b) and also defines transactions considered to be economically similar to a repurchase including certain acquisitive reorganizations, split-offs and certain overlap complete liquidations. Further, the notice defines transaction that are not economically similar transactions including complete liquidations and certain divisive transactions.

Recent Accounting Pronouncements

In August 2020, FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments.

The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2023, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06 on its financial statements.

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

XML

PUBLIC OFFERING

6 Months Ended

Jun. 30, 2023

PUBLIC OFFERING

PUBLIC OFFERING

NOTE 3 ─ PUBLIC OFFERING

On March 25, 2021, the Company closed on the sale of 12,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of the Company’s common stock, $0.0001 par value and one-half of one redeemable Public Warrant. Each whole Public Warrant offered in the Offering is exercisable to purchase one share of the Company’s common stock at an exercise price of $11.50 per share.

On March 30, 2021, the underwriters exercised the over-allotment option in part and purchased an additional 843,937 Units, generating gross proceeds of $8.44 million.

In connection with the Public Offering, the Company granted the underwriters an option to purchase 1,800,000 shares of the Company’s common stock at the Public Offering price, or $10.00 per share, for 45 days commencing on October 25, 2021 (grant date). Since this option extended beyond the closing of the Public Offering, this option feature represented a call option that was accounted for under ASC 480, Distinguishing Liabilities from Equity. Accordingly, the call option has been separately accounted for at a fair value with the change in fair value between the grant date and March 30, 2021 and expiration amount recorded as other income. The Company used the Black-Scholes valuation model to determine the fair value of the call option at the grant date and again at March 30, 2021 (refer to Note 9 for fair value information).

XML

PRIVATE UNITS

6 Months Ended

Jun. 30, 2023

PRIVATE UNITS

PRIVATE UNITS

NOTE 4 ─ PRIVATE UNITS

Concurrently with the closing of the Public Offering, the Sponsor and the underwriters purchased an aggregate of 390,000 Private Units generating gross proceeds of $3.90 million in aggregate in a private placement. Each private unit consists of one share of the Company’s common stock, $0.0001 par value and one-half of one redeemable Private Warrant. Each whole Private Warrant will entitle the holder to purchase one share of common stock at a price of $11.50 per full share, subject to adjustment (see Note 8).

As a result of the underwriters’ election to partially exercise their over-allotment option on March 30, 2021, the Sponsor and the underwriters and its designees purchased an additional 16,879 Private Units, at a purchase price of $10.00 per Private Unit.

If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

XML

RELATED PARTY TRANSACTIONS

6 Months Ended

Jun. 30, 2023

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Each loan would be evidenced by promissory note.

The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1.50 million of notes may be converted upon completion of a Business Combination into units at a price of $10.00 per unit. Such units would be identical to the Private Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

NOTE 5 – RELATED PARTY TRANSACTIONS (Continued)

Related Party Loans (Continued)

On May 3, 2022, the Company issued a promissory note for up to approximately $0.4 million (the “Note”) to the Sponsor, of which $0.4 million was outstanding under the Note as of December 31, 2022. The Note is non-interest bearing and the Company must make drawdown requests in amounts no less than $10,000 unless otherwise agreed upon by the parties. The principal balance of the Note is payable on the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective (such date, the “Maturity Date”). The Company, pursuant to the Note, may at any time prior to payment in full of the principal balance of the Note elect to convert all or any portion of the unpaid principal balance of the Note into units at a conversion price of $10.00 per unit.

However, on March 15, 2023, the Company amended and restated the Note (the “Amended Note”) in its entirety to (1) increase the principal amount thereunder from $0.4 million to $0.9 million and (2) remove the right of the holder of the Amended Note to convert all or any portion of the unpaid principal balance of the note into the Company’s units and related registration rights for such units (including underlying securities). The Amended Note is non-interest bearing and is payable on the Maturity Date.

On March 22, 2023, the Company amended and restated the Note (the “Second Amended Note”) to increase the principal amount of up to $0.9 million to up to $2.1 million to the Sponsor, pursuant to which the Sponsor agreed to loan to the Company up to such amount.

In April 2023, $49,140 was drawn down under the Second Amended Note. In May 2023, an additional aggregate of $221,449 was drawn down under the Second Amended Note. In June 2023, an additional aggregate of $83,500 was drawn down, and an aggregate of $102,665 was refunded, under the Second Amended Note.

At June 30, 2023 and December 31, 2022, approximately $0.72 million and $0.40 million were outstanding under the Second Amended Note, respectively.

Extension Loan

The Sponsor or its designees have agreed to contribute to the Company as a note to fund the Contribution. The Initial Contribution was deposited into the Trust Account on March 24, 2023. Additionally, an aggregate of $200,000 per month of Monthly Extension Fee will be funded throughout the Extension Period, or portion thereof, that is needed to complete an initial Business Combination, which amount will be deposited into the Trust Account.

On June 26, 2023, a Monthly Extension Fee of $200,000 was deposited into the Trust Account, which was comprised of a $100,000 payment from the Sponsor, bringing the balance of the extension loan outstanding to $0.7 million as of June 30, 2023. The other $100,000 payment was from Infinite Reality and this amount is non-reimbursable by the Company or the Sponsor.

Related Party Payable

As of June 30, 2023, an amount of $480 was payable to the Sponsor, in connection with the filing of a tax return.

Administrative Support Agreement

The Company has agreed to pay the Sponsor a total of up to $0.01 million per month from the effective date of the Registration Statement for office space, utilities and secretarial and administrative support. Services will terminate upon the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company. For the six months ended June 30, 2023, the Company has accrued $0.06 million for these services. For the six months ended June 30, 2022, the Company paid $0.04 million and accrued $0.02 million for these services. These amounts are included in the operating costs on the accompanying condensed statements of operations.

XML

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Jun. 30, 2023

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

NOTE 6 – COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on March 22, 2021, the holders of the Founder Shares and Representative Shares, as well as the holders of the Private Units (and underlying securities) and any warrants issued in payment of Working Capital Loans made to Company (and underlying securities) are entitled to registration rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities.

The holders of a majority of the Representative Shares, Private Units and warrants issued in payment of Working Capital Loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. Notwithstanding anything to the contrary, EBC may only make a demand on one occasion and only during the five-year period beginning on the effective date of the registration statement of which this prospectus forms a part. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to consummation of a Business Combination; provided, however, that EBC may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the registration statement of which this prospectus forms a part.

The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of Public Offering to purchase up to 1,800,000 additional Units to cover over-allotments, if any, at the Public Offering price less the underwriting discounts and commissions.

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $2.40 million in the aggregate, paid at the closing of the Public Offering.

On March 30, 2021, the underwriters partially exercised their over-allotment option to purchase an additional 843,937 Units at $10.00 per Unit.

In connection with the underwriters’ partial exercise of the over-allotment option on March 30, 2021, the underwriters were paid an additional cash underwriting fee of approximately $0.17 million.

NOTE 6 – COMMITMENTS AND CONTINGENCIES (Continued)

Business Combination Marketing Agreement

The Company has engaged EBC as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination.

The Company will pay EBC a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of Public Offering (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at the Company’s sole discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.

Additionally, the Company will pay EBC a cash fee equal to 1.0% of the total consideration payable in a Business Combination if EBC introduces the Company to the target business with which the Company completes a Business Combination; provided that the foregoing fee will not be paid prior to the date that is 90 days from the effective date of the Public Offering, unless FINRA determines that such payment would not be deemed underwriters’ compensation in connection with the Public Offering pursuant to FINRA Rule 5110(c)(3)(B)(ii).

XML

STOCKHOLDERS' DEFICIT

6 Months Ended

Jun. 30, 2023

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT

NOTE 7 ─ STOCKHOLDERS’ DEFICIT

Preferred Stock

The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

Common Stock

The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. On January 15, 2021, the Company issued 4,562,500 shares of common stock to the Sponsor and the underwriters and its designees. On March 22, 2021, the Sponsor and the underwriters effected a surrender of 862,500 and 50,000 shares of common stock to the Company, for no consideration. This resulted in a decrease in the total number of shares of common stock outstanding from 4,562,500 to 3,650,000. All shares and associated amounts have been retroactively restated to reflect the share surrender.

On March 30, 2021, as a result of the underwriters’ election to partially exercise the over-allotment option, an aggregate of 239,016 Founder Shares has been forfeited. As of June 30, 2023 and December 31, 2022, there were 3,817,863 shares of common stock issued and outstanding, excluding 5,099,852 shares of common stock as of June 30, 2023, and 12,843,937 shares of common stock as of December 31, 2022, respectively, that are subject to possible redemption at the option of the holders which accordingly are classified as temporary equity in the accompanying balance sheets.

NOTE 7 ─ STOCKHOLDERS’ DEFICIT (Continued)

Public Warrants

The Public Warrants will become exercisable at any time commencing 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available.

If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company may redeem the Public Warrants (excluding the Private Warrants and any warrants underlying units issued upon conversion of the Working Capital Loans):

● in whole and not in part;

● at a price of $0.01 per warrant;

● at any time after the warrants become exercisable;

● upon not less than 30 days’ prior written notice of redemption to each warrant holder;

● if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and

● if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

NOTE 7 ─ STOCKHOLDERS’ DEFICIT (Continued)

Public Warrants (Continued)

In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) Market Value or (ii) the price at which the Company issue the additional shares of common stock or equity-linked securities.

Representative Shares

If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

In January 2021, the Company issued to EBC and its designees, 250,000 Representative Shares.

On March 22, 2021, 50,000 Representative Shares were returned by EBC and its designees to the Company, for no consideration. This resulted in a decrease in the total number of Representative Shares outstanding from 250,000 to 200,000.

The Company accounted for the Representative Shares as an offering cost of the Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of Representative Shares to be $1,449 based upon the price of the Founder Shares issued to the Sponsor.

The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their redemption rights with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period.

The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Public Offering pursuant to Rule 5110(g)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities were not sold during the Public Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the Public Offering, except to any underwriter and selected dealer participating in the Public Offering and their bona fide officers or partners, provided that all securities so transferred remain subject to the lockup restriction above for the remainder of the time period.

XML

DERIVATIVE WARRANTS LIABILITIES

6 Months Ended

Jun. 30, 2023

DERIVATIVE WARRANTS LIABILITIES

DERIVATIVE WARRANTS LIABILITIES

NOTE 8 – DERIVATIVE WARRANTS LIABILITIES

The Private Warrants are identical to the Public Warrants underlying the Units being sold in the Public Offering, except that the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable or saleable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

XML

FAIR VALUE MEASUREMENTS

6 Months Ended

Jun. 30, 2023

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

NOTE 9 – FAIR VALUE MEASUREMENTS

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

● Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

● Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

● Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.

The fair value of the Private Warrants was initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Warrants have been estimated using a Monte Carlo simulation model each measurement date.

For the six months ended June 30, 2023, the Company recognized a loss to the statements of operations resulting from an increase in the fair value of liabilities of $24,413, and for the six months ended June 30, 2022, the Company recognized a gain to the statements of operations resulting from a decrease in the fair value of liabilities of $95,617, respectively, presented as change in fair value of derivative warrant liabilities in the accompanying statements of operations.

NOTE 9 – FAIR VALUE MEASUREMENTS (Continued)

The following table presents information about the Company’s financial assets and liablities that were measured at fair value on a recurring basis at June 30, 2023, by level within the fair value hierarchy:

	Quoted Prices in		Significant Other		Significant Other
	Active Markets		Observable Inputs		Unobservable Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Derivative warrant liabilities - Private	$	—	$	—	$	38,654
	$	—	$	—	$	38,654

At June 30, 2023, assets held in the Trust Account comprised of $53.3 million in an interest-bearing Demand Deposit Account.

The following table presents information about the Company’s financial assets and liablities that were measured at fair value on a recurring basis as of December 31, 2022, by level within the fair value hierarchy:

			Significant		Significant
	Quoted Prices		Other		Other
	in Active		Observable		Unobservable
	Markets		Inputs		Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Assets:
Treasury Bills	$	129,951,121	$	—	$	—
	$	129,951,121	$	—	$	—
Liabilities:
Derivative warrant liabilities - Private	$	—	$	—	$	14,241
	$	—	$	—	$	14,241

Transfers to/from Levels 1, 2 and 3 were recognized at the end of the reporting period.

The estimated fair value of the Private Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

NOTE 9 – FAIR VALUE MEASUREMENTS (Continued)

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:

	June 30, 2023			December 31, 2022
Exercise price	$	11.50		$	11.50
Stock price		10.38			9.71
Volatility		5.3	%		10.4	%
Probability of completing a Business Combination		90.1	%		90.0	%
Term (in years)		5.26			5.74
Risk-free rate		4.03	%		1.32	%

The change in the fair value of the derivative warrant liabilities for the three and six months ended June 30, 2023, is summarized as follows:

Derivative warrant liabilities at December 31, 2022	$	14,241
Change in fair value of derivative warrant liabilities		(5,106)
Derivative warrant liabilities at March 31, 2023		9,135
Change in fair value of derivative warrant liabilities		29,519
Derivative warrant liabilities at June 30, 2023	$	38,654

XML

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2023

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE 10 – SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Other than as described herein, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

On July 21, 2023, the Company, Pubco, Purchaser Merger Sub, Company Merger Sub and Infinite Reality entered into the Second Merger Amendment to provide for the addition of a new Section 6.24 pursuant to which Infinite Reality agrees to pay a “Monthly Extension Fee” of $0.2 million per month directly into the Trust Account on behalf of the Company, on or before the date when such payment becomes due, until the completion of the Mergers. In addition, if the Merger Agreement is terminated for any reason other than a breach by the Company, Infinite Reality agrees to pay all expenses of the Company incurred after March 31, 2023, provided that in no event shall such payment exceed $3 million (inclusive of all Monthly Extension Fees paid). In the event that the Mergers are consummated, the Company agrees to pay for all transaction expenses up to $10 million in connection with the consummation of the Mergers and the other transactions contemplated by the Merger Agreement.

On July 21, 2023, pursuant to the Second Merger Amendment, Infinite Reality deposited a Monthly Extension Fee of $0.2 million directly into the Trust Account on behalf of the Company, bringing the balance of the Contribution outstanding to $1.0 million. Any monthly extension payment deposited into the Trust Account by Infinite Reality is nonreimbursable by the Company or the Sponsor.

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Jun. 30, 2023

SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the GAAP for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 31, 2023. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.

Emerging Growth Company

Emerging Growth Company

The Company is an “emerging growth company” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2023 and December 31, 2022, the Company did not have any cash equivalents, outside of funds held in the Trust Account.

As of June 30, 2023 and December 31, 2022, the Company had cash of approximately $0.01 million and $0.08 million, respectively, outside of funds held in the Trust Account.

Cash Held in Trust Account

Cash Held in Trust Account

At June 30, 2023 and December 31, 2022, the Company had approximately $53.33 million and $129.95 million, respectively, of assets held in the Trust Account in an interest-bearing demand deposit account and in Treasury Bills. respectively.

On April 3, 2023, approximately $78.8 million was removed from the Trust Account in connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders subsequent to the approval of the Extension Proposal.

On April 11, 2023, the Company liquidated the funds held in the Trust Account and instead holds the funds in the Trust Account in an interest bearing demand deposit account until the earlier of the consummation of our Business Combination or the Company’s liquidation.

On June 26, 2023, a Monthly Extension Fee of $200,000 was deposited into the Trust Account, which was comprised of a $100,000 payment from the Sponsor and a $100,000 payment from Infinite Reality. The monthly extension payment of $100,000 deposited into the Trust Account by Infinite Reality is non-reimbursable by the Company or the Sponsor.

On July 21, 2023, pursuant to the Second Merger Amendment, Infinite Reality deposited a Monthly Extension Fee of $200,000 directly into the Trust Account on behalf of the Company, bringing the balance of the Contribution outstanding to $1.0 million. Any monthly extension payment deposited into the Trust Account by Infinite Reality is non-reimbursable by the Company or the Sponsor.

Common Stock Subject to Possible Redemption

Common Stock Subject to Possible Redemption

All of the 12,843,937 shares of common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation if there is a stockholder vote or tender offer in connection with the Business Combination. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC Topic 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC Topic 480.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of common stock are affected by charges against additional paid-in capital and accumulated deficit.

As of June 30, 2023 and December 31, 2022, the shares of common stock subject to possible redemption and included as temporary equity were as follows:

	As of		As of
	June 30, 2023		December 31, 2022
Gross proceeds	$	129,951,121	$	128,439,370
Plus:
Accretion of carrying value to redemption value		1,558,248		1,511,751
Stockholders redemptions		(78,770,623)		—
Contingently redeemable common stock	$	52,738,744	$	129,951,121

Offering Costs

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are charged against the carrying value of common stock or stockholders’ deficit based on the relative value of the shares of common stock and the warrants, to the proceeds received from the Units sold upon the completion of the Public Offering. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Public Offering that were directly related to the Public Offering. The Company incurred offering costs amounting to $3.00 million as a result of the Public Offering, consisting of $2.57 million of cash underwriting discount and $0.43 million of other offering costs. As such, the Company recorded $2.90 million of offering costs as a reduction of temporary equity, $0.10 million of offering costs as a reduction of permanent equity and $454 of offering cost as reduction in the statement of operations.

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the federal depository insurance coverage of $0.25 million. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

● Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

● Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

● Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

As of June 30, 2023 and December 31, 2022, the carrying values of cash, prepaid expenses, accrued expenses, franchise tax payable approximated their fair values due to the short-term nature of the instruments.

Derivative Warrant Liabilities

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Subtopic 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The 203,440 Private Warrants are recognized as derivative liabilities in accordance with ASC Subtopic 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the Private Warrants was initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Warrants have been estimated using a Monte Carlo simulation model each measurement date.

Net (Loss) Profit Per Share of Common Stock

Net (Loss) Profit Per Share of Common Stock

The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net  (loss) profit per share of common stock is computed by dividing the pro rata net  (loss) profit between the shares of common stock subject to redemption and the shares of common stock not subject to redemption by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted (loss) profit per share of common stock does not consider the effect of the warrants issued in connection with the Public Offering since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 6,625,409 shares of common stock in the aggregate.

	Three Months Ended		Three Months Ended		Six Months Ended		Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Common stock subject to possible redemption
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$	(44,219)	$	(55,584)	$	219,413	$	(242,585)
Denominator:
Weighted average shares outstanding, redeemable common stock		5,099,852		12,843,937		8,541,668		12,843,937
Basic and diluted net (loss) profit per share, redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)
Non-redeemable common stock
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$	(33,103)	$	(16,522)	$	98,071	$	(72,108)
Denominator:
Weighted average shares outstanding, non-redeemable common stock		3,817,863		3,817,863		3,817,863		3,817,863
Basic and diluted net (loss) profit per share, non-redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)

Income Taxes

Income Taxes

The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.

The Company recorded income tax expense of $0.49 million based on activities through June 30, 2023, primarily as a result of investment income, partially offset by deductible expenses. The Company's year to date effective tax rate for the second quarter ended June 30, 2023 was 60.61% compared to (1.31%) in the year to date second quarter ended June 30, 2022. The Company's effective rate for the standalone second quarter ended June 30, 2023 was 262% compared to 5.98% in the standalone second quarter ended June 30, 2022. The 2023 year to date effective rate of 60.61% differs from the statutory tax rate of 21% mainly due to permanent nondeductible GAAP expenses, state income taxes and change in the valuation allowance. The standalone second quarter ended June 30, 2023 effective rate of 262% differs from the statutory tax rate of 21% mainly due to permanent non-deductible GAAP expenses, state income taxes and change in the valuation allowance.

The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.

The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying statement of operations. As of June 30, 2023, the Company does not have uncertain tax positions or interest and penalties related to uncertain tax positions.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was enacted into law. Among other changes to the tax code, the act imposes a 1% excise tax on certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022. The stock buyback tax may be applicable to certain SPAC redemptions, including in connection with a SPAC’s business combination. For purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, a number of exceptions to the stock buyback tax are available including exceptions to certain reorganizations; however, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension a vote by stockholders to extend the period of time to complete the Business Combination (the “extension vote”) or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. As of June 30, 2023, $0.79 million was incurred by the Company as excise tax expense in connection with the redemption of 7,744,085 shares of common stock previously held by public stockholders.

The IRS issued Notice 2023-3 (Initial guidance regarding the application of the excise tax on repurchases of corporate stock). The notice defines stock redemptions per Internal Revenue Code (IRC) section 317(b) and also defines transactions considered to be economically similar to a repurchase including certain acquisitive reorganizations, split-offs and certain overlap complete liquidations. Further, the notice defines transaction that are not economically similar transactions including complete liquidations and certain divisive transactions.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In August 2020, FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments.

The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2023, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06 on its financial statements.

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

XML

SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2023

SIGNIFICANT ACCOUNTING POLICIES

Schedule of common stock subject to possible redemption and included as temporary equity

	As of		As of
	June 30, 2023		December 31, 2022
Gross proceeds	$	129,951,121	$	128,439,370
Plus:
Accretion of carrying value to redemption value		1,558,248		1,511,751
Stockholders redemptions		(78,770,623)		—
Contingently redeemable common stock	$	52,738,744	$	129,951,121

Schedule of Net (loss) profit per share of common stock

	Three Months Ended		Three Months Ended		Six Months Ended		Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Common stock subject to possible redemption
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$	(44,219)	$	(55,584)	$	219,413	$	(242,585)
Denominator:
Weighted average shares outstanding, redeemable common stock		5,099,852		12,843,937		8,541,668		12,843,937
Basic and diluted net (loss) profit per share, redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)
Non-redeemable common stock
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$	(33,103)	$	(16,522)	$	98,071	$	(72,108)
Denominator:
Weighted average shares outstanding, non-redeemable common stock		3,817,863		3,817,863		3,817,863		3,817,863
Basic and diluted net (loss) profit per share, non-redeemable common stock	$	(0.00)	$	(0.00)	$	0.03	$	(0.02)

XML

FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Jun. 30, 2023

FAIR VALUE MEASUREMENTS

Schedule of company's financial assets and liabilities that were measured at fair value on a recurring basis

The following table presents information about the Company’s financial assets and liablities that were measured at fair value on a recurring basis at June 30, 2023, by level within the fair value hierarchy:

	Quoted Prices in		Significant Other		Significant Other
	Active Markets		Observable Inputs		Unobservable Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Derivative warrant liabilities - Private	$	—	$	—	$	38,654
	$	—	$	—	$	38,654

At June 30, 2023, assets held in the Trust Account comprised of $53.3 million in an interest-bearing Demand Deposit Account.

The following table presents information about the Company’s financial assets and liablities that were measured at fair value on a recurring basis as of December 31, 2022, by level within the fair value hierarchy:

			Significant		Significant
	Quoted Prices		Other		Other
	in Active		Observable		Unobservable
	Markets		Inputs		Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Assets:
Treasury Bills	$	129,951,121	$	—	$	—
	$	129,951,121	$	—	$	—
Liabilities:
Derivative warrant liabilities - Private	$	—	$	—	$	14,241
	$	—	$	—	$	14,241

Schedule of quantitative information regarding Level 3 fair value measurements inputs

	June 30, 2023			December 31, 2022
Exercise price	$	11.50		$	11.50
Stock price		10.38			9.71
Volatility		5.3	%		10.4	%
Probability of completing a Business Combination		90.1	%		90.0	%
Term (in years)		5.26			5.74
Risk-free rate		4.03	%		1.32	%

Schedule of change in the fair value of the warrant liabilities

Derivative warrant liabilities at December 31, 2022	$	14,241
Change in fair value of derivative warrant liabilities		(5,106)
Derivative warrant liabilities at March 31, 2023		9,135
Change in fair value of derivative warrant liabilities		29,519
Derivative warrant liabilities at June 30, 2023	$	38,654

XML

ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Details) - USD ($)				6 Months Ended
	May 15, 2023	Apr. 03, 2023	Mar. 25, 2023	Jun. 30, 2023	Jul. 21, 2023	Dec. 31, 2022
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Threshold minimum aggregate fair market value as a percentage of the net assets held in the trust account				80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination				50.00%
Purchase price, per unit				$ 10.00
Minimum net tangible assets upon consummation of business combination				$ 5,000,001
Threshold percentage of public shares subject to redemption without company's prior written consent				20.00%
Combination period			24 months
Threshold business days for redemption of public shares				10 days
Maximum net interest to pay dissolution expenses				$ 100,000
Cash in operating bank account				14,472		$ 83,643
Cash held in Trust Account				53,327,162		$ 129,951,121
Cash removed from Trust Account in connection with redemption		$ 78,800,000
Working capital				$ (5,130,000)
Maximum
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Transaction expenses in connection with mergers	$ 10,000,000
Subsequent Events
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Cash held in Trust Account					$ 200,000
Common Stock
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Number of shares redeemed				7,744,085

XML

ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS - Stockholder extension meeting (Details) - USD ($)				6 Months Ended
	Jul. 21, 2023	Jun. 26, 2023	Apr. 03, 2023	Jun. 30, 2023	Mar. 24, 2023	Mar. 21, 2023
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Redemption amount				$ (78,770,623)
Sponsor
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Aggregate initial contribution amount of note that the sponsor or its designees have agreed to contribute						$ 600,000
Initial contribution amount per public share that is not redeemed on a monthly basis, that the sponsor or its designees have agreed to contribute as a note						$ 0.04
Amount of per month contribution by Sponsor that will be deposited in Trust Account					$ 600,000	$ 200,000
Payments for fees		$ 100,000
Sponsor or its Designees | Extension loan
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Monthly extension fee		200,000
Infinite Reality
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Payments for fees		$ 100,000
Common stock subject to possible redemption
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Number of shares redeemed			7,744,085
Redemption price per share			$ 10.17
Redemption amount			$ 78,800,000
Subsequent Events
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
Monthly extension fee	$ 200,000
Expenses incurred	3,000,000
Maximum amount of transaction expenses	10,000,000
Outstanding contribution balance	$ 1,000,000.0

XML

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)				3 Months Ended		6 Months Ended
	Jul. 21, 2023	Jun. 26, 2023	Apr. 03, 2023	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Mar. 25, 2021
SIGNIFICANT ACCOUNTING POLICIES
Cash equivalents				$ 0		$ 0		$ 0
Cash				10,000.00		10,000.00		80,000.00
Assets held in trust account in treasury bills				$ 53,327,162		53,327,162		$ 129,951,121
Amount withdrawn from Trust Account for redemption of common stock						$ 539,786	$ 9,500
Common stock subject to possible redemption				5,099,852		5,099,852		12,843,937
Cash, FDIC insured amount				$ 250,000		$ 250,000
Warrants exercisable for shares of common stock				6,625,409		6,625,409
Income tax expense				$ 125,049	$ 4,066	$ 488,418	$ 4,066
Effective tax rate percentage				262.00%	5.98%	60.61%	1.31%
Ettective tax rate				262.00%		60.61%
Statutory tax rate percentage					21.00%		21.00%
Accrued interest and penalties				$ 0		$ 0
Offering cost									$ 3,000,000.00
Cash underwriting discount									2,570,000
Other offering costs									430,000
Offering costs as a reduction of temporary equity									2,900,000
Offering costs as a reduction in permanent equity									100,000
Offering costs as a reduction in statement of operations									$ 454
Subsequent Events
SIGNIFICANT ACCOUNTING POLICIES
Assets held in trust account in treasury bills	$ 200,000
Monthly extension fee	200,000
Outstanding contribution balance	$ 1,000,000.0
Sponsor
SIGNIFICANT ACCOUNTING POLICIES
Payments for fees		$ 100,000
Monthly extension fee non-reimbursable		100,000
Infinite Reality
SIGNIFICANT ACCOUNTING POLICIES
Payments for fees		100,000
Extension loan | Sponsor or its Designees
SIGNIFICANT ACCOUNTING POLICIES
Monthly extension fee		$ 200,000
Private Placement Warrants
SIGNIFICANT ACCOUNTING POLICIES
Derivative liabilities (in warrants)						203,440
Common Stock
SIGNIFICANT ACCOUNTING POLICIES
Number of shares redeemed						7,744,085
Excise tax expense				$ 790,000		$ 790,000
Common stock subject to possible redemption
SIGNIFICANT ACCOUNTING POLICIES
Amount withdrawn from Trust Account for redemption of common stock			$ 78,800,000
Number of shares redeemed			7,744,085
Common stock subject to possible redemption				5,099,852		5,099,852		12,843,937

XML

SIGNIFICANT ACCOUNTING POLICIES - Common Stock Subject to Possible Redemption (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES
Gross proceeds	$ 129,951,121	$ 128,439,370
Accretion of carrying value to redemption value	1,558,248	1,511,751
Stockholders redemptions	(78,770,623)
Contingently redeemable common stock	$ 52,738,744	$ 129,951,121

XML

SIGNIFICANT ACCOUNTING POLICIES - Net (Loss) Profit Per Share of Common Stock (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Common stock subject to possible redemption
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$ (44,219)	$ (55,584)	$ 219,413	$ (242,585)
Denominator:
Weighted average shares outstanding, basic	5,099,852	12,843,937	8,541,668	12,843,937
Weighted average shares outstanding, diluted	12,843,937	12,843,937	8,541,668	12,843,937
Basic net (loss) profit per share	$ 0.00	$ 0.00	$ 0.03	$ (0.02)
Diluted net (loss) profit per share	$ 0.00	$ 0.00	$ 0.03	$ (0.02)
Non-redeemable common stock
Numerator:
Net (loss) profit allocable to common stock subject to possible redemption	$ (33,103)	$ (16,522)	$ 98,071	$ (72,108)
Denominator:
Weighted average shares outstanding, basic	3,817,863	3,817,863	3,817,863	3,817,863
Weighted average shares outstanding, diluted	3,817,863	3,817,863	3,817,863	3,817,863
Basic net (loss) profit per share	$ 0.00	$ 0.00	$ 0.03	$ (0.02)
Diluted net (loss) profit per share	$ 0.00	$ 0.00	$ 0.03	$ (0.02)

XML

PUBLIC OFFERING (Details) - USD ($) $ / shares in Units, $ in Thousands				6 Months Ended
	Oct. 25, 2021	Mar. 30, 2021	Mar. 25, 2021	Jun. 30, 2023	Dec. 31, 2022
PUBLIC OFFERING
Number of units sold		843,937
Purchase price, per unit				$ 10.00
Common shares, par value, (per share)			$ 0.0001	$ 0.0001	$ 0.0001
Initial Public Offering
PUBLIC OFFERING
Number of units sold			12,000,000	1,800,000
Purchase price, per unit			$ 10.00
Granted term	45 days
Initial Public Offering | Public Warrants
PUBLIC OFFERING
Number of shares in a unit			1
Number of warrants in a unit			0.5
Number of shares issuable per warrant			1
Exercise price of warrants			$ 11.50
Over-allotment option
PUBLIC OFFERING
Number of units sold		843,937
Proceeds received from initial public offering, gross		$ 8,440
Granted term				45 days

XML

PRIVATE UNITS (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 30, 2021	Mar. 25, 2021	Jun. 30, 2023
PRIVATE UNITS
Warrants exercisable for shares of common stock			6,625,409
Number of units sold	843,937
Purchase price, per unit			$ 10.00
Private Units | Warrants
PRIVATE UNITS
Warrants exercisable for shares of common stock		390,000
Aggregate purchase price		$ 3,900
Number of shares in a unit		1
Price of warrants		$ 0.0001
Number of warrants in a unit		0.5
Number of shares per warrant		1
Exercise price of warrant		$ 11.50
Private Units | Private Placement Warrants
PRIVATE UNITS
Number of units sold	16,879
Purchase price, per unit	$ 10.00

XML

RELATED PARTY TRANSACTIONS (Details) - USD ($)			6 Months Ended
	Jun. 26, 2023	Mar. 30, 2021	Jun. 30, 2023	Jun. 30, 2022	May 31, 2023	Apr. 30, 2023	Mar. 22, 2023	Mar. 21, 2023	Mar. 15, 2023	Mar. 14, 2023	Dec. 31, 2022	May 03, 2022
Related Party Transaction
Related party payable			$ 480								$ 480
Other Liability, Current, Related Party, Type [Extensible Enumeration]			us-gaap:RelatedPartyMember								us-gaap:RelatedPartyMember
Sponsor
Related Party Transaction
Shares forfeited		239,016
Related party payable			$ 480
Payments for fees	$ 100,000
Infinite Reality
Related Party Transaction
Payments for fees	100,000
Promissory Note with Related Party | Sponsor
Related Party Transaction
Aggregate principal amount												$ 400,000
Total outstanding balance			720,000								$ 400,000
Minimum amount of non-interest bearing drawdown			$ 10,000
Conversion price			$ 10.00
Face amount							$ 2,100,000	$ 900,000	$ 900,000	$ 400,000
Amount withdrawn under amended note			$ 102,665			$ 49,140
Further draw down under amended note			83,500		$ 221,449
Working capital loans
Related Party Transaction
Loan conversion agreement warrant			$ 1,500,000
Conversion price			$ 10.00
Extension loan | Sponsor
Related Party Transaction
Other payment from infinite reality non-reimbursable	100,000
Extension loan | Sponsor or its Designees
Related Party Transaction
Extension loan outstanding			$ 700,000
Extension loan			200,000
Administrative fees expense per month			10,000.00
Expenses incurred and paid				$ 40,000.00
Administrative fee accrued			$ 60,000.00	$ 20,000.00
Monthly extension fee	$ 200,000

XML

COMMITMENTS AND CONTINGENCIES (Details) $ / shares in Units, $ in Thousands				6 Months Ended
	Oct. 25, 2021	Mar. 30, 2021 USD ($) $ / shares shares	Mar. 25, 2021 shares	Jun. 30, 2023 USD ($) item $ / shares shares
COMMITMENTS AND CONTINGENCIES
Number of demands | item				2
Number of units sold		843,937
Underwriting cash discount per unit | $ / shares		$ 10.00		$ 0.20
Aggregate underwriter cash discount | $				$ 2,400
Additional underwriter cash discount | $		$ 170
Initial Public Offering
COMMITMENTS AND CONTINGENCIES
Granted term	45 days
Number of units sold			12,000,000	1,800,000
Over-allotment option
COMMITMENTS AND CONTINGENCIES
Granted term				45 days
Number of units sold		843,937
EarlyBirdCapital
COMMITMENTS AND CONTINGENCIES
Threshold period to make a demand from the effective date of the registration statement				5 years
Time period to participate in a "piggy-back" registration from the effective date of registration statement.				7 years
Cash fee as a percentage of gross proceeds of public offering				3.50%
Percentage of fee may be allocated at the company's sole discretion				30.00%
Cash fee as a percentage of total consideration payable in a business combination				1.00%
Condition of foregoing fee not to be paid before effective date of the public offering for cash fee equal to 1.0%				90 days

XML

STOCKHOLDERS' DEFICIT - Preferred stock shares (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
STOCKHOLDERS' DEFICIT
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

XML

STOCKHOLDERS' DEFICIT - Common stock shares (Details) - $ / shares	Mar. 30, 2021	Jun. 30, 2023	Dec. 31, 2022	Mar. 31, 2021	Mar. 25, 2021	Mar. 22, 2021	Jan. 15, 2021
STOCKHOLDERS' EQUITY
Common stock, shares authorized		100,000,000	100,000,000
Common stock, par value (in dollars per share)		$ 0.0001	$ 0.0001		$ 0.0001
Common stock, shares issued		3,817,863	3,817,863
Common stock, shares outstanding		3,817,863	3,817,863
Common stock subject to possible redemption		5,099,852	12,843,937
Minimum
STOCKHOLDERS' EQUITY
Common stock, shares outstanding				3,650,000
Maximum
STOCKHOLDERS' EQUITY
Common stock, shares outstanding				4,562,500
Sponsor
STOCKHOLDERS' EQUITY
Common stock, shares issued						862,500	4,562,500
Shares forfeited	239,016
Underwriters
STOCKHOLDERS' EQUITY
Common stock, shares issued						50,000

XML

STOCKHOLDERS' DEFICIT - Public warrants (Details)	6 Months Ended
	Jun. 30, 2023 D $ / shares
STOCKHOLDERS' EQUITY
Public warrants expiration term	5 years
Share price trigger used to measure dilution of warrant | $ / shares	$ 9.20
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant	60
Trading period after business combination used to measure dilution of warrant | D	20
Warrant exercise price adjustment multiple	115
Public Warrants
STOCKHOLDERS' EQUITY
Warrant exercise period condition one	30 days
Public warrants expiration term	5 years
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
STOCKHOLDERS' EQUITY
Redemption price per public warrant (in dollars per share) | $ / shares	$ 0.01
Redemption period	30 days
Warrant redemption condition minimum share price | $ / shares	$ 18.00
Threshold trading days for redemption of public warrants | D	20
Threshold consecutive trading days for redemption of public warrants | D	30

XML

STOCKHOLDERS' DEFICIT - Representative shares (Details) - USD ($)		1 Months Ended	6 Months Ended
	Mar. 22, 2021	Jan. 31, 2021	Jun. 30, 2023	Mar. 21, 2021
STOCKHOLDERS' EQUITY
Public warrants expiration term			5 years
Representative Shares | EarlyBirdCapital
STOCKHOLDERS' EQUITY
Number of shares issued		250,000
Number of shares returned	50,000
Consideration for shares returned	$ 0
Total number of shares outstanding	200,000			250,000
Fair value of representative shares			$ 1,449
Lock-up period			180 days

XML

FAIR VALUE MEASUREMENTS (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
FAIR VALUE MEASUREMENTS
Change in fair value of derivative warrant liabilities	$ (29,519)	$ 28,482	$ (24,413)	$ 95,617
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]			Change in fair value of derivative warrant liabilities	Change in fair value of derivative warrant liabilities
Assets:
Assets held in trust account in treasury bills	53,327,162		$ 53,327,162		$ 129,951,121
Level 1 | Recurring
Assets:
Assets held in trust account in treasury bills					129,951,121
Level 1 | Treasury Bills | Recurring
Assets:
Assets held in trust account in treasury bills					129,951,121
Level 3 | Recurring
Liabilities:
Derivative warrant liabilities - Private	38,654		38,654		14,241
Level 3 | Recurring | Private Placement Warrants
Liabilities:
Derivative warrant liabilities - Private	$ 38,654		$ 38,654		$ 14,241

XML

FAIR VALUE MEASUREMENTS - Level 3 fair value measurements inputs (Details)	Jun. 30, 2023 $ / shares Y	Dec. 31, 2022 Y $ / shares
FAIR VALUE MEASUREMENTS
Discount rate for lack of marketability	0
Exercise price | Level 3
FAIR VALUE MEASUREMENTS
Derivative liability, measurement input	11.50	11.50
Stock price | Level 3
FAIR VALUE MEASUREMENTS
Derivative liability, measurement input	10.38	9.71
Volatility | Level 3
FAIR VALUE MEASUREMENTS
Derivative liability, measurement input	0.053	0.104
Probability of completing a Business Combination | Level 3
FAIR VALUE MEASUREMENTS
Derivative liability, measurement input	0.901	0.900
Term (in years) | Level 3
FAIR VALUE MEASUREMENTS
Derivative liability, measurement input | Y	5.26	5.74
Risk-free rate | Level 3
FAIR VALUE MEASUREMENTS
Derivative liability, measurement input	0.0403	0.0132

XML

FAIR VALUE MEASUREMENTS - Change in the fair value of the warrant liabilities (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2023	Jun. 30, 2022
Fair value of the derivative warrant liabilities
Derivative warrant liabilities at the beginning	$ 9,135	$ 14,241	$ 14,241
Change in fair value of derivative warrant liabilities	29,519	(5,106)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]			Fair Value Adjustment of Warrants	Fair Value Adjustment of Warrants
Derivative warrant liabilities at the ending	$ 38,654	$ 9,135	$ 38,654

XML

SUBSEQUENT EVENTS (Details) - USD ($)	Jul. 21, 2023	Jun. 30, 2023	Dec. 31, 2022
SUBSEQUENT EVENTS
Cash held in Trust Account		$ 53,327,162	$ 129,951,121
Subsequent Events
SUBSEQUENT EVENTS
Monthly extension fee	$ 200,000
Expenses incurred	3,000,000
Maximum amount of transaction expenses	10,000,000
Cash held in Trust Account	200,000
Outstanding contribution balance	$ 1,000,000.0